As we continue our transition away from the DSL chipset market, most of our
resources, including research and development expenses, are allocated to the
development and promotion of our high-throughput wireless local area network, or
HT-WLAN chipsets. These products enable transport of digital broadband media
including video, voice and data at significantly higher rates than conventional
wireless local area networking (WLAN) solutions. The WLAN products support the
IEEE 802.11n standard, draft 2.0 of which was approved in March 2007.
Our principal executive offices are located at Yakum Business Park, Yakum
60972, Israel. Our telephone number is 972-9-960-5555. Our agent for service in
the United States is our subsidiary, Metalink Inc., which is located at 3260
Pointe Parkway, Suite 400, Norcross, Georgia 30092 (telephone number
678-325-5430).
Our address on the Internet is www.mtlk.com. THE INFORMATION ON OUR WEBSITE
IS NOT INCORPORATED BY REFERENCE INTO THIS PROSPECTUS.
FORWARD LOOKING STATEMENTS
We make statements in this prospectus that are considered forward-looking
statements under U.S. federal securities laws. We may from time to time make
forward-looking statements in our reports to the SEC on Form 20-F and Form 6-K,
in our annual report to shareholders, in offering circulars and prospectuses, in
press releases and other written materials, and in oral statements made by our
officers, directors or employees to analysts, institutional investors,
representatives of the media and others. Such forward-looking statements are
based on the beliefs of our management as well as assumptions made by and
information currently available to them. We urge you to consider that statements
which use the terms "believe," "do not believe," "expect," "plan," "intend,"
"estimate," "anticipate," and similar expressions are intended to identify
forward-looking statements. These statements reflect our current views with
respect to future events and are based on assumptions and are subject to risks
and uncertainties.
All forward-looking statements are subject to certain risks, uncertainties
and assumptions. If one or more of these risks or uncertainties materialize, or
if underlying assumptions prove incorrect, our actual results, performance or
achievements could differ materially from those expressed in, or implied by, any
such forward-looking statements. Important factors that could cause or
contribute to such difference include, among others, changes in general economic
and business conditions; any unforeseen developmental or technological
difficulties with regard to our products; timely availability and customer
acceptance of our new and existing products; changes in the competitive
landscape, including new competitors or the impact of competitive pricing and
products; changes in currency exchange rates and interest rates, and various
other factors, as well as those discussed in this prospectus under "Risk
Factors", our annual reports on Form 20-F, our reports on Form 6-K and other
reports filed with or furnished to the SEC.
You should not place undue reliance on such forward-looking statements,
which speak only as of their dates. Except as required by applicable law,
including the securities laws of the United States, we do not intend to update
or revise any forward-looking statements, whether as a result of new
information, future events or otherwise.
RISK FACTORS
BEFORE YOU INVEST IN OUR SECURITIES, YOU SHOULD CAREFULLY CONSIDER THE
RISKS INVOLVED. IN ADDITION, WE MAY INCLUDE ADDITIONAL RISK FACTORS IN A
PROSPECTUS SUPPLEMENT TO THE EXTENT THERE ARE ADDITIONAL RISKS RELATED TO THE
SECURITIES OFFERED BY THAT PROSPECTUS SUPPLEMENT. ACCORDINGLY, YOU SHOULD
CAREFULLY CONSIDER THE FOLLOWING FACTORS, OTHER INFORMATION IN THIS PROSPECTUS
OR IN THE DOCUMENTS INCORPORATED BY REFERENCE AND ANY ADDITIONAL RISK FACTORS
INCLUDED IN THE RELEVANT PROSPECTUS SUPPLEMENT:
RISKS RELATED TO OUR BUSINESS AND INDUSTRY
WE HAVE A HISTORY OF OPERATING LOSSES.
We have incurred significant operating losses since our inception, and we
may not achieve operating profitability in the foreseeable future. We reported
operating losses of approximately $17.5 million for the years ended December 31,
2005 and 2006, each, and $25.6 million for the year ended December 31, 2007. As
of December 31, 2007, our accumulated deficit was approximately $117.2 million.
We reported revenues of approximately $10.2 million for the year ended December
31, 2007. Our revenues may not grow and are likely to decline in the forseeable
future. Moreover, even if we are successful in increasing our revenues, we may
be delayed in doing so. If our revenues do not increase to keep pace with our
expenses or if our expenses increase at a greater pace than our revenues, we
will not be able to achieve profitability on a quarterly or annual basis. Even
if we achieve profitability, we cannot assure that future net income will offset
our accumulated deficit. This is likely to have an adverse impact on the value
of our stock.
3
WE WILL NEED TO RAISE ADDITIONAL FUNDS IN ORDER FOR US TO IMPLEMENT OUR CURRENT
BUSINESS PLAN, INCLUDING OUR LIQUIDITY REQUIREMENTS, WHICH FUNDS MAY NOT BE
AVAILABLE TO US.
In order for us to implement our current business plan, we will need to
raise additional funds in the near future to meet our anticipated working
capital requirements, capital expenditures and other operating requirements,
including:
o maintaining and/or expanding our research and development programs;
o recruiting management, technical, marketing and financial personnel;
o adapting to changing technologies and technical requirements;
o implementing further marketing and sales activities; and
o acquiring complementary businesses.
As of the date of this filing, we have initiated efforts to raise
additional capital. To that end, we may seek to sell additional equity
securities or debt securities or obtain debt financing. The sale of additional
equity securities or convertible debt securities would result in additional
dilution to our shareholders. Additional debt would result in increased expenses
and could result in covenants that would restrict our operations. However, we
cannot assure you that we will be able to obtain additional funds on a timely
basis, on acceptable terms or at all.
If we cannot raise sufficient funds or if adequate funds are not available
on acceptable terms, we may be unable to meet our business objectives and we are
likely to face liquidity problems during the year 2008 and we will have to
modify our current business plan, primarily to significantly reduce operating
expenses from their current level. In addition, if we cannot raise sufficient
funds or if adequate funds are not available, we may not be able to:
o develop new products;
o enhance our existing products;
o remain current with evolving industry standards;
o take advantage of future opportunities; or
o respond to competitive pressures or unanticipated requirements.
Any of these results could have a material adverse effect on our business,
financial condition and results of operations.
OUR STRATEGIC DECISION TO SHIFT OUR EFFORTS AWAY FROM DSL CHIPSETS, IN ORDER TO
FOCUS ON DEVELOPING HT-WLAN CHIPSETS, WILL REQUIRE US TO UTILIZE A SIGNIFICANT
AMOUNT OF RESOURCES, EVEN THOUGH THE RESULTS OF OUR STRATEGY ARE UNCERTAIN.
In early 2008, we issued an "end-of-life" notice to our customers,
according to which we are discontinuing the production of several of our digital
subscriber line, or DSL, components. Therefore, we do not expect any significant
revenues from our DSL chipsets beyond year 2008.
4
As we continue our transition away from the DSL chipset market, most of our
resources, including research and development expenses, are allocated to the
development and promotion of our high-throughput wireless local area network, or
HT-WLAN chipsets. As a result, we do not allocate any research and development
resources for DSL chipsets and have significantly reduced the scope of these
operations. As such, our future growth and profitability will be dependent on
revenues from our HT-WLAN chipsets, as opposed to revenues from our DSL
chipsets, which have historically accounted for a substantial portion of our
revenues.
We cannot be certain that the results of our HT-WLAN research and
development efforts will yield any revenues in the future. Our success with the
wireless product line may also be challenged by, among other things, new
technological barriers associated with wireless technologies, and sales and
marketing challenges associated with penetrating a new market, particularly,
since we have no previous track record in providing such services or products.
We expect that in the foreseeable future our revenues will be reduced as sales
of our DSL chipsets decline and significant revenues from HT-WLAN are not yet
realized.
OUR REVENUE GROWTH DEPENDS ON THE SUCCESS OF OUR HIGH-THROUGHPUT WLAN PRODUCTS.
Our revenue growth, if any, will be dependent upon revenues generated by
high-throughput WLAN products. Because this is a new product and market for us,
we do not know and are unable to predict whether the development phase will
succeed or that we will succeed in selling HT-WLAN products in the future.
IF THE MARKET FOR HT-WLAN SOLUTIONS DOES NOT DEVELOP, WE WILL NOT BE ABLE TO
SELL ENOUGH OF OUR CHIPSETS TO ACHIEVE, SUSTAIN OR INCREASE PROFITABILITY.
Sales of our WLANPLUS products are dependent, among other things, on the
development of the HT-WLAN market, and specifically networking and consumer
electronics manufactures of products incorporating HT-WLAN (based on the 802.11n
standard draft) such as residential gateways, access points, television sets,
digital video recorders, digital video disks, advanced set top boxes, and media
adaptors. If the market for digital and online entertainment, including
on-demand gaming, music and video services based on HT-WLAN chipsets does not
develop to incorporate our products, our financial condition, results of
operations, and prospects would be adversely affected.
SUBSTANTIAL SALES OF OUR HT-WLAN CHIPSETS WILL NOT OCCUR UNLESS END-CUSTOMERS
INCLUDING CONSUMER ELECTRONICS VENDORS INCORPORATE OUR CHIPSETS IN THEIR
PRODUCTS.
The success of our products is dependent upon the decision by
end-customers, including consumer electronics vendors, to incorporate our
chipsets in their products. Factors that may impact such sale include:
o challenges of interoperability among HT-WLAN based products, which may
affect sales of the products in which our chipsets are contained;
o government regulations, and a longer than anticipated 802.11n standard
approval process;
o a prolonged acceptance process for our HT-WLAN chipsets, including
laboratory testing, technical trials, marketing trials, initial
commercial deployment and full commercial deployment. During this
process we are subject to numerous tests and trials, at any stage of
which we may be stopped from continuing to the final stage of
commercial deployment. Moreover, the abovementioned process may take
longer and consume more of our resources than expected for reasons we
can not anticipate;
o the development of a viable business model for networking and consumer
electronics products based on our chipsets; and
o cost constraints, such as space and power requirements, which may
affect purchases of our chipsets.
5
A SLOWDOWN IN THE TELECOMMUNICATIONS INDUSTRY WOULD ADVERSELY AFFECT OUR
BUSINESS AND RESULTS OF OPERATIONS.
Telecommunications service providers and their customers are the principal
end-users of substantially all of our wireline products, and are potential
end-customers for part of our WLAN products. From time to time, the
telecommunications industry in much of the world, including in our principal
markets, has experienced significant downturns, resulting in decreases and
delays in the procurement and deployment of new telecommunications equipment. It
is likely that any prolonged and substantial curtailment of growth in the
telecommunications industry will have an adverse effect, which may be material,
upon us. Any such curtailment may result from circumstances unrelated to us or
our product offerings and over which we have no control. In addition, a market
perception that these conditions could have an impact on our company may harm
the trading prices of our shares, whether or not our business and results of
operations are actually affected.
CONDITIONS AND CHANGES IN THE NATIONAL AND GLOBAL ECONOMIC AND POLITICAL
ENVIRONMENTS MAY ADVERSELY AFFECT OUR BUSINESS AND FINANCIAL RESULTS.
Adverse economic conditions in markets in which we operate, which led to
recession fears, can harm our business. If economic growth in the United States
and other countries' economies is slowed, many customers may delay or reduce
technology purchases.
OUR QUARTERLY OPERATING RESULTS ARE VOLATILE. THIS MAY CAUSE OUR SHARE PRICE TO
DECLINE.
Our quarterly operating results and revenues have varied significantly in
the past and are likely to vary significantly in the future. These variations
result from a number of factors, many of which are substantially outside of our
control, including:
o Our revenues depend upon the size, timing and shipment of orders for
our chipsets, especially large orders from certain customers. We do
not receive orders in the same amounts each quarter;
o Our customers may not accurately forecast their needs or efficiently
manage their inventory positions;
o Our limited order backlog makes revenues in any quarter substantially
dependent on orders received and delivered in that quarter;
o Customers may cancel or postpone orders in our backlog;
o The timing and level of market acceptance for existing chipsets,
chipsets under development and new applications, or chipsets
introduced by us or by our competitors, is uncertain;
o The need to enter new markets and expand our current markets may delay
revenues and cause additional expenses;
o The effectiveness of our customers in marketing and selling their
equipment;
o Our profitability can be affected by the payment of royalties and
commissions to subcontractors such as intellectual property vendors or
sales representatives;
o Changes in pricing by us or by our competitors;
o Unfavorable changes in the prices of the components we purchase or
license;
o The fact that only a small portion of our expenses vary with our
revenues, if revenue levels for a quarter fall below our expectations,
our earnings will decrease;
6
o A delay in the receipt of revenue arising from postponement of orders
by customers or, shipping delays of existing orders, even from one
customer, may have a significant negative impact on our results of
operations for a given period. We have experienced such delays in the
past, and our results of operations for those periods were, as a
result, negatively affected;
o The mix of chipsets sold and the mix of sales channels through which
they are sold;
o Changes in resource allocation by our customers due to their operating
budget cycles;
o Deferrals of customer orders in anticipation of new applications or
new chipsets introduced by us or by our competitors;
o Delays in delivery by the subcontractors who manufacture our chips;
o New definition of products needed for the markets we address;
o Inventory write-offs and impairment of assets; and
o General economic and market sector conditions.
Because of historical variations in our quarterly operating results, a
period-to-period comparison of our results of operations may not be reliable as
an indicator of future performance.
Accordingly, our operating results may be below public expectations in
future fiscal periods. Our failure to meet these expectations may cause our
share price to decline.
THE LOSS OF ONE OR MORE OF OUR KEY CUSTOMERS WOULD RESULT IN A SIGNIFICANT LOSS
OF REVENUES.
Historically, relatively few customers have accounted for a large
percentage of our net revenues. Our business will be negatively impacted if
revenue projections from these customers fall short, or if we experience a loss
of any significant customer, particularly, ADC Teleccommunication, Inc., ECI
Telecom Ltd., Marconi Communication Italy, or Tellabs Oy, or suffer a
substantial reduction in orders from these customers. In 2007, four customers,
ECI Telecom Ltd., Marconi Communication Italy, ADC Teleccommunication, Inc. and
Tellabs Oy, each accounted for more than 10% of our revenues, and collectively
accounted, directly and through their respective manufacturing subcontractors,
for an aggregate of 69% of our revenues. We cannot be certain that these
customers will maintain these levels of purchases or that they will elect to
continue working with us. We do not have contracts with any of our customers
that obligate them to continue to purchase our chipsets, and these customers
could cease purchasing our chipsets at any time. We expect that sales of our
chipsets to certain key customers will continue to account for a significant
portion of our net revenues for the foreseeable future.
IF THE MARKET FOR WI-FI SOLUTIONS DOES NOT CONTINUE TO DEVELOP, WE WILL NOT BE
ABLE TO SELL ENOUGH OF OUR CHIPSETS TO ACHIEVE, SUSTAIN OR INCREASE
PROFITABILITY.
HT-WLAN solutions compete with a variety of different broadband access
technologies in home networking, including BPL- Broadband over Power Lines,
HomePNA - Home Phoneline Networking Alliance - broadband over existing home
telephone or coax wiring, MoCA - Multimedia over Coax Alliance, UWB -
Ultra-Wideb. If any technology that competes with HT-WLAN (based on the 802.11n
standard draft) technology is more reliable, faster or less expensive, and
reaches more customers, or has other advantages over HT-WLAN technology, the
demand for our chipsets will be limited, and we may not sell enough of our
chipsets to achieve, sustain or increase profitability. Furtehrmorwe, if the
market for 802.11n standard draft products will not evolve, our business result
will be severly harmed.
7
OUR INVESTMENTS IN AUCTION RATE SECURITIES ARE SUBJECT TO RISKS.
On December 31, 2007, we had long-term investments of $2.2 million, all of
which were held in auction rate securities, or ARS. ARS are securities that are
structured with short-term interest rate reset dates of generally less than
ninety days but with longer contractual maturities that range, for our holdings,
from 20 to 38 years. These securities are subject to fluctuations in fair value
depending on the supply and demand at each auction. While these debt securities
are all highly-rated investments, continued failure to sell at their reset dates
influenced the liquidity of our investment which in turn negatively influenced
the liquidity requirements of the Company. In addition, continued failure to
sell at their reset dates could also negatively impact the carrying value of the
investment in such ARS, which could lead to impairment charges in future periods
should a decline in the value of those securities be other than temporary, which
could have a material adverse effect on our financial position and results of
operations.
SUBSTANTIAL SALES OF OUR CHIPSETS WILL NOT OCCUR UNLESS END-CUSTOMER
TELECOMMUNICATIONS SERVICE PROVIDERS INCREASINGLY DEPLOY DSL SYSTEMS OR WLAN
PRODUCTS.
The success of our DSL products and part of our WLAN products is dependent
upon, among others, the decision by end-customer telecommunications service
providers to deploy DSL systems and 802.11n standard draft based products that
include our chipsets and the timing of the deployment. Factors that may impact
such deployment include:
o the "end-of-life" announcement to some of our DSL products and our
investment of most of our research and development resources in the
development of HT-WLAN chipsets;
o a prolonged approval process, including laboratory tests, technical
trials, marketing trials, initial commercial deployment and full
commercial deployment. During this process we are subject to numerous
tests and trials, under which we may not continue to the final stage
of commercial deployment. Furthermore, this process may take longer to
conclude than expected, for reasons we can not anticipate;
o the development of a viable telecommunications service provider
business model for DSL systems and services and 802.11n standard draft
based products, including the capability to market, sell, install and
maintain DSL systems and services and 802.11n standard draft based
products;
o cost constraints, such as installation costs and space and power
requirements at the telecommunications service provider's central
office, which may affect purchases of DSL systems and 802.11n standard
draft based products that contain our chipsets;
o varying and uncertain conditions of the local loop, including the size
and length of the copper wire, electrical interference and
interference with existing voice and data telecommunications services;
o challenges of interoperability among DSL equipment manufacturers'
products and 802.11n standard draft based products, which may affect
sales of the systems in which our chipsets are contained; and
o government regulations, including regulations of telecommunications
service providers' rates and ability to recapture capital expenditures
on DSL systems and 802.11n standard draft based products by
governments in the United States and around the world.
If telecommunications service providers do not expand their deployment of DSL
systems or 802.11n standard draft based products, or if additional
telecommunications service providers do not offer DSL services or 802.11n
standard draft based products, our results of operations and prospects will be
harmed.
8
CHANGES IN CURRENT TELECOMMUNICATIONS LAWS OR REGULATIONS OR THE IMPOSITION OF
NEW LAWS OR REGULATIONS COULD IMPEDE THE SALE OF OUR PLANNED WIRELESS PRODUCTS
OR OTHERWISE HARM OUR BUSINESS.
Wireless networks can only operate in the frequency bands, or spectrum,
allowed by regulators and in accordance with rules governing how the spectrum
can be used. The Federal Communications Commission, or the FCC, in the United
States, as well as regulators in other countries, have broad jurisdiction over
the allocation of frequency bands for wireless networks. Our business relies on
the FCC and international regulators to provide sufficient spectrum and usage
rules. For example, countries such as China, Japan and Korea heavily regulate
all aspects of their wireless communications industries, and may restrict
spectrum allocation or usage, or may impose requirements that render our
products or our customers' products unmarketable in these jurisdictions. If this
were to occur, it would make it difficult or impossible for us to sell our
products in that region. In addition, some of our chipsets will operate in the 5
gigahertz, or GHz band, which is also used by government and commercial services
such as military and commercial aviation. The FCC and European regulators have
traditionally protected government uses of the 5GHz bands by setting power
limits and indoor and outdoor designation and requiring that wireless local area
networking devices not interfere with other users of the band such as government
and civilian satellite services. Changes in current laws or regulations,
reversal of usage rights, or the imposition of new laws and regulations
regarding the allocation and usage of the 5GHz band on us, our customers or the
industries in which we operate may materially and adversely impact the sales of
our products and our business, financial condition and results of operations.
EVOLVING AND CURRENT INDUSTRY STANDARDS FOR DSL AND WIRELESS TECHNOLOGIES COULD
AFFECT THE END-MARKET FOR OUR PRODUCTS.
Evolving and current industry standards for DSL and wireless technologies
may affect the end-market for our DSL products. In particular, this may have an
adverse effect on our very high-speed digital subscriber line, or VDSL, and
wireless business. For example, with regard to VDSL technology, in 2004, the
International Telecommunication Union, or ITU, reached agreement on a new global
standard that specifies the application of the two main technologies used for
encoding signals for DSL - Discrete MultiTone (DMT) technology and Quadrature
Amplitude Modulation (QAM) - to VDSL technology. However, in 2005 the ITU
ratified a VDSL2 standard based on the existing ADSL2 and VDSL standards that
specify DMT modulation only. Our existing VDSL chipsets are based on QAM.
Currently, most of the future deployment of VDSL chipsets require only the VDSL2
standard of DMT. Thus, our VDSL sales suffer from lack of demand, and shall
continue to be adversely affected in the future. With regard to wireless
products, we design our products to conform to the standards of the IEEE
(Institute of Electrical and Electronics Engineers, Inc.) which adopted draft
802.11n specification in 2007. The fact that final IEEE ratified standard has
not been approved yet can influence the deployment rate of 802.11n products. We
also depend on industry groups such as the WiFi Alliance to certify and maintain
certification of our products. If our customers adopt new or competing industry
standards with which our products will not be compatible, or such industry
groups fail to adopt standards with which our products will be compatible, or if
we are unable to complete development of products based on the draft
specification on a timely basis, our business will be adversely harmed.
IF THE ORIGINAL EQUIPMENT MANUFACTURERS AND ORIGINAL DESIGN MANUFACTURERS THAT
UTILIZE OUR CHIPSETS ARE NOT SUCCESSFUL IN SELLING THEIR SYSTEMS, SALES OF OUR
CHIPSETS WILL DECLINE SIGNIFICANTLY.
We rely upon original equipment manufacturers, or OEMs, and original design
manufacturers, or ODMs, to integrate our chipsets into their systems. If their
systems are not successful, or they choose not to purchase our chipsets, or they
fail to incorporate our chipsets into their systems, we will not be able to sell
them our chipsets in substantial quantities. Moreover, they may fail to market
or sell their systems successfully. Their systems may be unsuccessful for a
large number of reasons, substantially all of which are beyond our control.
SINCE WE HAVE LIMITED VISIBILITY AS TO THE VOLUME OF SALES OF OUR PRODUCTS BY
OUR CUSTOMERS AND INVENTORY LEVELS OF OUR PRODUCTS HELD BY OUR CUSTOMERS, OUR
ABILITY TO FORECAST ACCURATELY FUTURE DEMAND FOR AND SALES OF OUR PRODUCTS IS
LIMITED.
We sell our chipsets to OEMs who integrate our chipsets into their products
or to ODMs who include our chipsets in the products they supply to OEMs. We have
limited visibility as to the volume of our products that our OEM and ODM
customers are selling to their customers or carrying in their inventory. If our
customers have excess inventory or experience a slowing of products sold through
to their end customers, it would likely result in a slowdown in orders from our
customers and adversely impact our future sales and inventory.
OUR CHIPSETS MAY NOT ADEQUATELY SERVE THE NEEDS OF END USERS.
Our chipsets are sold primarily through OEMs or ODMs. Thus, the feedback
that we receive with respect to the field performance of our chipsets from
telecommunication service providers and their users may be limited. This may
impair our ability to design chipsets that are responsive to the needs of the
end users of our chipsets. This may harm the market acceptance of our chipsets.
9
IF WE DO NOT ACHIEVE "DESIGN WINS" WITH OEMS OR WITH ODMS DURING THE DESIGN
STAGE OF A NEW PRODUCT, WE MAY BE UNABLE TO SECURE PRODUCTION ORDERS FROM THESE
CUSTOMERS IN THE FUTURE.
We sell our products directly to OEMs, who include our chipsets in their
products, and to ODMs, who include the chipsets in the products they supply to
OEMs. Our products are generally incorporated into our customers' products at
the design stage. As a result, we rely on OEMs\ODMs to incorporate our products
into the products they sell. Once a DSL or a wireless equipment manufacturer has
designed its system to include a particular supplier's chip set, the equipment
manufacturer may be reluctant to change its source of chipsets. Furthermore,
even if an OEM\ODM designs one of our products into its product offering, we
cannot be assured that its product will be commercially successful, that we will
receive any revenue from that manufacturer or that a successor design will
include one of our products. Accordingly, the failure to secure a customer
contract or commitment to collaborate at the development stage or to develop and
test our chipsets within their system could create barriers to future sales
opportunities. The absence of such equipment manufacturer and/or design
manufacturer relationships would negatively affect our ability to achieve
long-term success.
WE MUST DEVELOP NEW CHIPSETS AND NEW APPLICATIONS FOR OUR EXISTING CHIPSETS TO
REMAIN COMPETITIVE. IF WE FAIL TO DO SO ON A TIMELY BASIS, WE MAY LOSE OR NOT
GAIN MARKET SHARE.
The markets for DSL and wireless solutions such as ours are characterized
by:
o rapid technological changes;
o frequent new product introductions;
o changes in customer requirements; and
o evolving industry standards.
Accordingly, our future success will depend, to a substantial extent, on
our ability to:
o invest significantly in research and development;
o develop, introduce and support new chipsets and new applications for
existing chipsets on a timely basis;
o gain market acceptance of our chipsets;
o implement successful cost reduction activities;
o anticipate customer requirements; and
o comply with industry standards.
As we announced "end of life" to some of our DSL products and invest most
of our research and development resources in the development of HT-WLAN
chipsets, we expect to lose our market share in DSL to our competitors and our
revenues from DSL products will therefore continue to decline.
BECAUSE COMPETITION IN THE MARKET FOR OUR SOLUTIONS IS INTENSE, WE MAY LOSE
MARKET SHARE, AND WE MAY BE UNABLE TO ACHIEVE OR MAINTAIN PROFITABILITY.
Our market is highly competitive, and we expect competition to intensify in
the future. We may not be able to compete effectively in our market, and we may
lose market share to our competitors. Our principal competitors in the DSL
market include Conexant Systems, Inc., Ikanos Communications Inc., Infineon
Technologies AG, and Mindspeed Technologies, Inc. Our competitors in the
wireless LAN market include Atheros Communications, Inc., Broadcom Corporation,
Conexant Systems, Inc., Intel Corporation, Marvell Technology Group Ltd.,
Qualcomm Inc. (formerly Airgo Networks, Inc.), Ralink Technology Corp. and Texas
Instruments Incorporated. We expect to continue to face competition from these
and other competitors. Larger companies with substantial resources, brand
recognition and sales channels may form alliances or merge with, or acquire
competing chip set providers and emerge as significant competitors. In addition,
competitors may bundle their products or incorporate a DSL or a wireless chip
set component into existing products in a manner that renders our chipsets
obsolete.
10
UNLIKE OUR COMPETITORS, WE HAVE NOT DESIGNED OUR OWN NETWORK PROCCESSOR, WHICH
MIGHT CAUSE US A LOSS OF POTENTIAL CUSTOMERS, AND THEREFORE CAN HARM OUR
BUSINESS.
In order to provide a complete chipset solution to potential customers in
the routers retail market, we must provide also a Network Processor in addition
to our WLAN chipset. Currently, we do not have our own Network Processor and we
rely on third parties to provide the Network Processor. Some of our customers in
the routers retail market may view this as a disadvantage compared to our
competitors who are able to offer customers a complete chipset solution.
COMPETITION MAY RESULT IN LOWER PRICES AND A CORRESPONDING REDUCTION IN OUR
ABILITY TO RECOVER OUR COSTS. THIS MAY IMPAIR OUR ABILITY TO ACHIEVE OR MAINTAIN
PROFITABILITY.
We expect that price competition among wireless chip set suppliers will
reduce our gross margins in the future. We anticipate that average selling
prices of our chipsets will continue to decline as product technologies mature.
Since we do not manufacture our own chipsets, we may be unable to reduce our
manufacturing costs in response to declining average per unit selling prices.
Many of our competitors are larger and have greater resources than we do.
Consequently, these competitors may be able to achieve greater economies of
scale and may be less vulnerable to price competition. Declines in average
selling prices will generally lead to declines in gross margins for chipsets. If
we are unable to recover costs, we will be unable to achieve profitability.
IN ORDER TO ATTAIN AND MAINTAIN PROFITABILITY, WE MUST MANAGE OUR RESOURCES
EFFECTIVELY IN A VOLATILE MARKET.
We had 162 employees at December 31, 2006 and 230 employees at December 31,
2007. Although we have recently implemented a cost reduction plan, the growth of
our business and the transition from our DSL products to WLAN products has
placed, and may continue to place, a strain on our managerial, operational and
financial resources. To manage resources effectively, we must, among others:
o improve and expand our management information systems (MIS) from time
to time;
o hire, train, manage and retain qualified employees for current
business and especially when the business is growing, and, when
industry conditions decline, reduce the workforce; and
o effectively manage relationships with our customers, subcontractors,
suppliers and other third parties.
If we are unable to manage our resources effectively, our revenues may not
increase, our costs of operations may increase and our business may be harmed.
BECAUSE WE OPERATE IN INTERNATIONAL MARKETS, WE ARE SUBJECT TO ADDITIONAL RISKS.
We currently offer our chipsets in a number of countries, through
independent sales representatives and distributors, and we intend to enter
additional geographic markets. Our business is subject to risks which often
characterize international markets, including:
o multiple, conflicting and changing laws and regulations;
o trade restrictions including higher tariffs that favor local
businesses in some countries;
o difficulties of managing sales representatives, especially because we
expect to increase our sales through our sales representatives;
11
o inadequate local infrastructure and transportation delays;
o financial risks, such as longer payment cycles, greater difficulty
collecting accounts receivable and exposure to foreign currency
exchange rate fluctuations;
o potentially weak protection of intellectual property rights;
o economic and political instability;
o import or export licensing requirements;
o difficulties in collecting accounts receivable;
o unexpected changes in regulatory requirements and tariffs;
o seasonal reductions in business activities in some parts of the world,
such as during the summer months in Europe;
o the impact of regional epidemics, such as SARS;
o fluctuations in exchange rates;
o potentially adverse tax consequences; and
o language and cultural differences.
Any of these factors could significantly harm our future international sales and
operations, and consequently, our revenue and results of operations and business
and financial condition. These risks may impair our ability to generate revenues
from our increased global sales efforts.
BECAUSE OF OUR LONG PRODUCT DEVELOPMENT PROCESS AND SALES CYCLE, WE MAY INCUR
SUBSTANTIAL EXPENSES BEFORE WE EARN ASSOCIATED REVENUES.
We incur substantial product development and marketing expenditures prior
to generating associated revenues. We do not receive substantial orders for our
chipsets during the period that potential customers test and evaluate our
chipsets. This period typically lasts from six to twelve months or longer, and
volume production of products that incorporate our chipsets typically does not
begin until this test and evaluation period has been completed. As a result, a
significant period of time may elapse between our product development and sales
efforts and any realization by us of revenues from volume ordering of our
chipsets by our customers, or we may never realize revenues from our efforts.
BECAUSE WE DO NOT HAVE LONG-TERM CONTRACTS WITH OUR CUSTOMERS, OUR CUSTOMERS CAN
DISCONTINUE PURCHASES OF OUR CHIPSETS AT ANY TIME, WHICH MAY ADVERSELY AFFECT
OUR INVENTORY LEVELS.
We sell our chipsets based on individual purchase orders. Our customers are
not obligated by long-term contracts to purchase our chipsets. Our customers can
generally cancel or reschedule orders upon short notice. Furthermore, achieving
a design win with a customer does not necessarily mean that this customer will
order large volumes of our products. A design win is not a binding commitment by
a customer to purchase our chipsets. Rather, it is a decision by a customer to
use our chipsets in the design process of that customer's products. A customer
can discontinue using our chipsets at any time. In the past we have experienced
cancellations or deferrals of purchase orders, and additional cancellations and
deferrals may occur from time to time. We have historically placed firm orders
for products with our foundries up to approximately 16 weeks prior to the
anticipated delivery date and typically prior to receiving an order for the
product. Therefore, our order volumes are based on our forecasts of demand from
our customers. This process requires us to make multiple demand forecast
assumptions, each of which may introduce error into our estimates. If we
overestimate customer demand or incorrectly estimate product mix, we may
allocate resources to manufacturing products that we may not be able to sell
when we expect or at all. As a result, we would have excess inventory, which
would harm our financial results. Conversely, if we underestimate customer
demand or if insufficient manufacturing capacity is available, we would forgo
revenue opportunities, lose market share and damage our customer relationships.
12
WE CURRENTLY RELY ON A LIMITED NUMBER OF SUBCONTRACTORS TO MANUFACTURE AND
ASSEMBLE OUR CHIPS.
We rely on a single subcontractor for the manufacture of a majority of the
chips included in our chipsets and on a limited number of subcontractors for the
assembly of finished chips and other related services. Our subcontractors
manufacture, assemble and test our chips in Singapore, the Republic of China
(Taiwan), Hong Kong, China, and the United States. These subcontractors
currently have limited manufacturing capacity, which may be inadequate to meet
our demand. If the operations of our subcontractors were halted, even
temporarily, or if they were unable to operate at full capacity for an extended
period of time, we could experience business interruption, increased costs, loss
of goodwill and loss of customers. Delays in the manufacture of chipsets are
typical in our industry, and we have experienced these delays in the past. The
Asia-Pacific region has experienced significant earthquakes in the past and
could be subject to additional seismic activities. Natural disasters,
earthquakes, and regional epidemics, could also have a negative impact on our
suppliers, and as a result significantly disrupt our operations.
WE ARE DEPENDENT UPON A LIMITED NUMBER OF SUPPLIERS OF KEY COMPONENTS.
We currently obtain key components from a single supplier or from a limited
number of suppliers. We generally do not have long-term supply contracts with
our suppliers. These factors subject us to the following risks:
o delays in delivery or shortages in components could interrupt and
delay the manufacturing and delivery of our chipsets and may result in
cancellation of orders by our customers;
o suppliers could increase component prices significantly and with
immediate effect;
o we may not be able to develop alternative sources for chip set
components, if and as required, in the future;
o suppliers could discontinue the manufacture or supply of components
used in our chipsets. In such event, we might need to modify our
chipsets, which may cause delays in shipments, increased manufacturing
costs and increased chipsets prices; and
o we may hold more inventory than is immediately required to compensate
for potential component shortages or discontinuance.
WE MAY EXPERIENCE DELAYS IN THE DELIVERY OF COMPONENTS FROM OUR SUPPLIERS.
Delays and shortages in the supply of components are typical in our
industry. We have experienced delays and shortages on more than one occasion in
the past. In addition, failure of worldwide semiconductor manufacturing capacity
to rise along with a rise in demand could result in our subcontract
manufacturers allocating available capacity to other customers, including
customers that are larger or have long-term supply contracts in place. Our
inability to obtain adequate foundry capacity at acceptable prices, or any delay
or interruption in supply, could reduce our revenues or increase our cost of
revenue and could harm our business and results of operations.
THE EUROPEAN UNION HAS ISSUED DIRECTIVES RELATING TO THE SALE IN MEMBER
COUNTRIES OF ELECTRICAL AND ELECTRONIC EQUIPMENT, INCLUDING PRODUCTS SOLD BY US.
IF OUR PRODUCTS FAIL TO COMPLY WITH THESE DIRECTIVES, WE COULD BE SUBJECT TO
PENALTIES AND SANCTIONS THAT COULD MATERIALLY ADVERSELY AFFECT OUR BUSINESS.
A directive issued by the European Union on the Restriction of the Use of
Certain Hazardous Substances in Electrical and Electronic Equipment, or "RoHS,"
came into effect in July 2006. The RoHS directive lists a number of substances
including, among others, lead, mercury, cadmium and hexavalent chromium, which
must either be removed or reduced to within maximum permitted concentrations in
any products containing electrical or electronic components that are sold within
the European Union. Our products meet the requirements of the RoHS directive and
we are making every effort in order to maintain compliance, without otherwise
adversely affecting the quality and functionalities of our products.
13
We, like other manufacturers, are dependent on our suppliers for certain
components and sub-system modules to comply with these requirements, and we may
be required to pay higher prices for components that comply with this directive.
In addition, compliance with the RoHS directive may require us to undertake
significant expenses with respect to the re-design of our products. We may not
be able to pass these higher component costs or re-design costs on to our
customers. We cannot be sure that we will be able to comply with these
regulations on a cost effective basis or that a sufficient supply of compliant
components will be available to us. Our inability or failure to comply with
these regulations, including by reason of failure by our suppliers to comply
with the directive, may restrict us for a period of time from conducting certain
business in the European Union and could have a material adverse effect on our
results of operations.
A further European Union directive on Waste Electrical and Electronic
Equipment, or "WEEE," approved by the European Union in 2003, promotes waste
recovery with a view to reducing the quantity of waste for disposal and saving
natural resources, in particular by reuse, recycling and recovery of waste
electrical and electronic equipment. The WEEE directive covers all electrical
and electronic equipment used by consumers and electronic equipment intended for
professional use. The directive, which partly came into effect in August 2005,
requires that all new electrical and electronic equipment put on the market in
European Union be appropriately labeled regarding waste disposal and contains
other obligations regarding the collection and recycling of waste electrical and
electronic equipment. We support the WEEE and conform to the industry standard
practices wherever practical. If we fail to maintain compliance, we may be
restricted from conducting certain business in the European Union, which could
adversely affect our results of operations.
The countries of the European Union, as a single market for our products,
accounted in 2007 for approximately 43% of our revenues. If our products fail to
comply with WEEE or RoHS directives or any other directive or similar regulation
issued from time to time by the European Union or in other countries in which we
operate, we could be subject to penalties and other sanctions that could have a
material adverse affect on our results of operations and financial condition.
UNDETECTED HARDWARE AND SOFTWARE ERRORS MAY INCREASE OUR COSTS AND IMPAIR THE
MARKET ACCEPTANCE OF OUR CHIPSETS.
Our chipsets may contain undetected errors. This may result either from
errors we have failed to detect or from errors in components supplied by third
parties. These errors are likely to be found from time to time in new or
enhanced chipsets after commencement of commercial shipments. Because our
customers integrate our chipsets into their systems with components from other
vendors, when problems occur in a system/product it may be difficult to identify
the component which has caused the problem. Regardless of the source of these
errors, we will need to divert the attention of our engineering personnel from
our product development efforts to address the detection of the errors. We may
incur significant warranty and repair costs related to errors, and we may also
be subject to liability claims for damages related to these errors. The
occurrence of errors, whether caused by our chipsets or the components of
another vendor, may result in significant customer relations problems and injury
to our reputation and may impair the market acceptance of our chipsets.
OUR SUCCESS DEPENDS ON OUR ABILITY TO ATTRACT, TRAIN AND RETAIN QUALIFIED
ENGINEERS, SALES AND TECHNICAL SUPPORT PERSONNEL.
If our business develops, we will need to hire additional engineers and
highly trained technical support personnel in Israel, North America, Europe and
in the Asia Pacific region. We currently have a small technical support staff.
To support any growth, we will need to increase our technical staff to support
new customers and the expanding needs of existing customers as well as our
continued research and development operations.
14
Hiring highly qualified engineers and technical support personnel is
competitive in our industry, due to the limited number of people available with
the necessary skills and understanding of our products. Our success depends upon
our ability to attract, train and retain highly qualified engineers and
technical support personnel.
The loss of any key employees or the inability to attract or retain
qualified personnel, including engineers and sales and marketing personnel,
could delay the development and introduction of, and harm our ability to sell
our products and harm the market's perception of us.
There is currently a shortage of qualified technical personnel with
significant experience in the design, development, manufacture, marketing and
sales of integrated circuits for use in wireless products. Our key technical
personnel and consultants represent a significant asset and serve as the source
of our technological and product innovations. We may not be successful in
attracting and retaining sufficient numbers of technical personnel to support
our business plan.
Our chipsets require a sophisticated marketing and sales effort targeted at
several levels within a prospective customer's organization. As competition for
qualified sales personnel continues, we may not be able to hire sufficient sales
personnel to support our marketing efforts.
WE ARE DEPENDENT ON OUR KEY PERSONNEL, IN PARTICULAR TZVI SHUKHMAN, OUR CHIEF
EXECUTIVE OFFICER, THE LOSS OF WHOM WOULD NEGATIVELY AFFECT OUR BUSINESS.
We believe our future success will depend in large part on the continued
services of our senior management and key personnel. In particular, we are
highly dependent on the services of Tzvi Shukhman, our chief executive officer.
All of our employees have entered into employment contracts with us except for
Mr. Shukhman. We do not carry key person life insurance on our senior management
or key personnel and they are not bound by long-term employment contracts. Any
loss of the services of Tzvi Shukhman, other members of senior management or
other key personnel could negatively affect our business.
OUR PROFITABILITY COULD SUFFER IF THIRD PARTIES INFRINGE UPON OUR PROPRIETARY
TECHNOLOGY.
Our profitability could suffer if third parties infringe upon our
intellectual property rights or misappropriate our technologies or trademarks
for their own businesses. To protect our intellectual property rights, we rely
on a combination of patent, trademark and copyright law, trade secret
protection, confidentiality agreements and other contractual arrangements with
our employees, affiliates, strategic partners and others. We currently hold two
patents in Israel and three patents in the United States. We have also filed
additional eleven utility patent applications in the United States, which are
pending at various stages. The protective steps we have taken may be inadequate
to deter misappropriation of our proprietary information. We may be unable to
detect the unauthorized use of, or take appropriate steps to enforce our
intellectual property rights. Moreover, pursuant to current U.S. and Israeli
laws, we may not be able to enforce existing non-competition agreements.
Effective patent, trademark, copyright and trade secret protection may not be
available in every country in which we offer, or intend to offer, our products.
Any failure to adequately protect our intellectual property could devalue our
proprietary interest and impair our ability to compete effectively. Furthermore,
defending our intellectual property rights could result in the expenditure of
significant financial and managerial resources.
OUR PRODUCTS MAY INFRINGE ON THE INTELLECTUAL PROPERTY RIGHTS OF OTHERS.
Third parties may assert against us infringement claims or claims that we
have violated a patent or infringed a copyright, trademark or other proprietary
right belonging to them. For example, the ownership by an unaffiliated third
party of a valid trademark with respect to the name Metalink, or the use of that
name by any unaffiliated third party (whether or not a valid trademark exists),
could cause confusion and otherwise have a material adverse effect upon our
business and financial condition. We have received from time to time in the past
written notices and offers from research institutions, intellectual property
holding firms and others claiming to have patent rights in certain technology
and inviting us to license this technology and related patent rights for use in
our products and methods. Such notices have also been sent to our customers. We
have responded directly, or indirectly through our customers, to all of these
notices. None of these notices has resulted in litigation against us. We cannot
assure you that any of these or other third-parties will not pursue litigation
or assert their patent and other intellectual property rights against us in the
future. We have certain indemnification obligations to customers with respect to
infringement of third-party patents and intellectual property rights by our
products. We cannot assure you that our potential obligations to indemnify such
customers will not harm us, our business or our financial condition and results
of operations. The results of any litigation are inherently uncertain. Any
successful infringement claim or litigation against us could result in the
expenditure of significant financial and managerial resources.
15
OUR PRODUCTS MAY REQUIRE LICENSING OF THE INTELLECTUAL PROPERTY RIGHTS OF
OTHERS.
We incorporate certain third party technology into our products, including
memory cells, input/output cells, digital and analog cores. Were we unable to
use or license these technologies on commercially viable terms, we could sustain
damage to our margins. If these third party technologies contain or develop
defects, we may be subject to warranty or other claims that could damage our
business.
WE MAY ENCOUNTER DIFFICULTIES WITH ACQUISITIONS, WHICH COULD HARM OUR BUSINESS.
We may make investments in complementary companies, products or
technologies. If we acquire a company, we may have difficulty integrating that
company's personnel, operations, products and technologies. These difficulties
may disrupt our ongoing business, distract our management and employees and
increase our expenses.
RISK FACTORS RELATING TO OUR ORDINARY SHARES
A MAJORITY OF THE COMPANY'S OUTSTANDING SHARES ARE HELD BY TWO INDIVIDUALS, WHO
EXERT SIGNIFICANT CONTROL OVER THE COMPANY'S DIRECTION.
As of July 1, 2008, Messrs. Tzvi Shukhman and Uzi Rozenberg, who are
directors of the Company, held an aggregate of 10,685,654 of ordinary shares,
representing 45.49% of our outstanding shares. Mr. Shukhman is also our chief
executive officer, and Mr. Rozenberg is also the Chairman of our Board of
Directors. As a result, if these shareholders vote together, they could control
the outcome of various actions that require shareholder approval. For example,
these shareholders could elect all of our directors, delay or prevent a
transaction in which shareholders might receive a premium over the prevailing
market price for their shares and prevent changes in control or management.
In 2003, we filed a registration statement with the SEC, covering the
resale by Messrs. Shukhman and Rozenberg of 10,565,651 of our ordinary shares.
Were they to sell all of those shares, they would no longer have the ability to
direct the voting of those shares, and new management could be elected.
In addition, because these shares are held by affiliates of the Company,
they are not generally considered to be included in the "public float" of the
Company's tradable shares. The market price for all shares could drop
significantly if and as these shares are sold, or if the market perceives that
such a sale as imminent.
VOLATILITY OF OUR SHARE PRICE COULD ADVERSELY AFFECT OUR SHAREHOLDERS.
The market price of our ordinary shares is likely to be highly volatile and
could be subject to wide fluctuations in response to numerous factors, including
the following:
o actual or anticipated variations in our quarterly operating results or
those of our competitors;
o announcements by us or by our competitors of technological
innovations;
o introduction and adoption of new industry standards;
o introductions of new products by us or by our competitors;
o announcements by us or by securities analysts of changes in financial
estimates;
16
o conditions or trends in our industry;
o changes in the market valuations of our competitors;
o announcements by us or by our competitors of significant acquisitions;
o entry into strategic partnerships or joint ventures by us or by our
competitors;
o additions or departures of key personnel;
o change in the status of our intellectual property rights;
o sales of ordinary shares;
o stock market price and volume fluctuations;
o announcements by us or by our competitors of significant events; or
o sales of ordinary shares by principal shareholders or management.
Many of these factors are beyond our control and may materially adversely
affect the market price of our ordinary shares, regardless of our performance.
As a result, investors may not be able to resell their ordinary shares
following periods of volatility because of the market's adverse reaction to that
volatility. In addition, the stock market in general, and the market for Israeli
and technology companies in particular, has been highly volatile. We cannot
assure you that our ordinary shares will trade at the same levels of shares of
other technology companies or that shares of technology companies in general
will sustain their current market prices.
OUR ORDINARY SHARES ARE LISTED FOR TRADING ON MORE THAN ONE MARKET AND THIS MAY
RESULT IN PRICE VARIATIONS.
Our ordinary shares have been listed for trading on the NASDAQ Global
Market, or NASDAQ, since December 2, 1999. As of December 3, 2000, our ordinary
shares have also been listed for trading on the Tel Aviv Stock Exchange, or
TASE. Trading in our ordinary shares on these markets is made in different
currencies (U.S. dollars on NASDAQ and NIS on TASE) and at different times
(resulting from different time zones, different trading days and different
public holidays in the United States and Israel). The trading prices of our
ordinary shares on these two markets often differ, resulting from the factors
described above, as well as differences in exchange rates. Any decrease in the
trading price of our ordinary shares on one of these markets could cause a
decrease in the trading price of our ordinary shares on the other market.
Volatility of the price of our ordinary shares on either market is likely to be
reflected on the price of our ordinary shares on the other market.
IF WE ARE CHARACTERIZED AS A PASSIVE FOREIGN INVESTMENT COMPANY, OUR U.S.
SHAREHOLDERS MAY SUFFER ADVERSE TAX CONSEQUENCES.
If, for any taxable year, our passive income, or our assets that produce
passive income, exceed specified levels, we may be characterized as a passive
foreign investment company ("PFIC") for U.S. federal income tax purposes for
that year and possibly also for later years. We were a PFIC during the years
2002 and 2003, but not in the years 2004, 2005, 2006 and 2007. We have not yet
determined whether we are likely to be characterized as a PFIC for 2008. If we
are characterized as a PFIC, our U.S. shareholders may suffer adverse tax
consequences. These consequences may include having gains realized on the sale
of our ordinary shares treated as ordinary income, rather than capital gains,
and having the highest possible tax rates in prior years, together with
significant interest charges, apply to substantial portions of those gains and
of certain distributions, if any, that we make, whether or not we have any
earnings and profits. U.S. shareholders should consult their own U.S. tax
advisers with respect to the U.S. tax consequences of investing in our ordinary
shares.
17
IF WE FAIL TO MAINTAIN EFFECTIVE INTERNAL CONTROLS IN ACCORDANCE WITH SECTION
404 OF THE SARBANES-OXLEY ACT OF 2002, IT COULD HAVE A MATERIAL ADVERSE EFFECT
ON OUR BUSINESS, OPERATING RESULTS AND STOCK PRICE.
The Sarbanes-Oxley Act of 2002 imposes certain duties on us. Our efforts to
comply with the management assessment requirements of Section 404, which apply
to us for the first time for our financial statements for 2007, have resulted in
increased general and administrative expenses and a devotion of management time
and attention to compliance activities, and we expect these efforts to require
the continued commitment of significant resources. If we fail to maintain the
adequacy of our internal controls, we may not be able to ensure that we can
conclude on an ongoing basis that we have effective internal control over
financial reporting. In addition, we may identify material weaknesses or
significant deficiencies in our internal control over financial reporting.
Failure to maintain effective internal control over financial reporting could
result in investigation and/or sanctions by regulatory authorities, and could
have a material adverse effect on our business and operating results, investor
confidence in our reported financial information, and the market price of our
ordinary shares.
WE MAY NOT SATISFY THE NASDAQ GLOBAL MARKET'S REQUIREMENTS FOR CONTINUED
LISTING. IF WE CANNOT SATISFY THESE REQUIREMENTS, NASDAQ COULD DELIST OUR
ORDINARY SHARES.
Our ordinary shares are listed on the NASDAQ Capital Market, or NASDAQ, under
the symbol MTLK. To continue to be listed on the NASDAQ, we will need to satisfy
a number of conditions, including a minimum bid price of at least $1.00 per
share. On August 13, 2008, we received a NASDAQ Staff Deficiency Letter
indicating that, for the 30 consecutive business days prior to the date of the
letter, the bid price of our ordinary shares closed below the minimum bid price
requirement of $1.00 per share. We generally have 180 calendar days, or until
February 9, 2009, to regain compliance with such requirement.
We cannot assure you that we will be able to satisfy the minimum bid, or
continue to meet the other continued listing requirements of NASDAQ in the
future. If we are delisted from the NASDAQ, trading in our ordinary shares may
be conducted, if available, on the NASDAQ Capital Market, "OTC Bulletin Board
Service" or another medium. In the event of such delisting, an investor would
likely find it significantly more difficult to dispose of, or to obtain accurate
quotations as to the value of our ordinary shares, and our ability to raise
future capital through the sale of our ordinary shares could be severely
limited.
RISKS RELATING TO OUR LOCATION IN ISRAEL
CONDITIONS IN ISRAEL AFFECT OUR OPERATIONS AND MAY LIMIT OUR ABILITY TO PRODUCE
AND SELL OUR PRODUCTS.
We are incorporated under the laws of the State of Israel, and our
principal offices and research and development facilities are located in Israel.
Accordingly, political, economic and military conditions in Israel directly
affect our operations.
Over the past several decades, a number of armed conflicts have taken place
between Israel and its Arab neighbors and a state of hostility, varying in
degree and intensity, has led to security and economic problems for Israel.
Since late 2000, there has been a high level of violence between Israel and the
Palestinians which has strained Israel's relationship with its Arab citizens,
Arab countries and, to some extent, with other countries around the world. The
election in 2006 of representatives of the Hamas movement to a majority of the
seats in the Palestinian Legislative Council and its subsequent seizure of
control of the Gaza strip have created additional unrest and uncertainty in the
region. Further, since mid- 2007, Hamas and other Palestinian movements have
been launching, from time to time, missile strikes from the Gaza strip into
southern Israel. Any armed conflicts or political instability in the region,
including acts of terrorism or any other hostilities involving or threatening
Israel, would likely negatively affect business conditions and could make it
more difficult for us to conduct our operations in Israel, which could increase
our costs and adversely affect our financial results.
18
SOME OF OUR DIRECTORS AND OFFICERS AS WELL AS MANY OF OUR ISRAELI EMPLOYEES ARE
OBLIGATED TO PERFORM ANNUAL MILITARY RESERVE DUTY IN ISRAEL. WE CANNOT ASSESS
THE POTENTIAL IMPACT OF THESE OBLIGATIONS ON OUR BUSINESS.
Some of our directors, officers and employees are currently obligated to
perform annual reserve duty and are subject to being called to active duty at
any time under emergency circumstances and could be required to serve in the
military for extended periods of time. Our operations could be disrupted by the
absence for a significant period of time of one or more of our officers or key
employees, or a significant number of other employees because of military
service. The full impact on our workforce or business if some of our officers
and employees are called upon to perform military service, especially in times
of national emergency, is difficult to predict. Any disruption in our operations
as the result of military service by directors, officers or employees could harm
our business.
PROVISIONS OF ISRAELI LAW MAY DELAY, PREVENT OR COMPLICATE MERGER OR ACQUISITION
ACTIVITY, WHICH COULD DEPRESS THE MARKET PRICE OF OUR SHARES.
Provisions of Israeli corporate, securities and tax law may have the effect
of delaying, preventing or making an acquisition of our company more difficult.
For example, under the Companies Law, upon the request of a creditor of either
party to a proposed merger, the court may delay or prevent the merger if it
concludes that there exists a reasonable concern that as a result of the merger
the surviving company will be unable to satisfy the obligations of any of the
parties to the merger. This and other provisions of Israeli law could cause our
ordinary shares to trade at prices below the price for which third parties might
be willing to pay to gain control of us, since third parties who are otherwise
willing to pay a premium over prevailing market prices to gain control of us may
be unable or unwilling to do so because of these provisions of Israeli law.
BECAUSE SUBSTANTIALLY ALL OF OUR REVENUES ARE GENERATED IN U.S. DOLLARS WHILE A
SIGNIFICANT PORTION OF OUR EXPENSES ARE INCURRED IN NIS OUR RESULTS OF
OPERATIONS MAY BE SERIOUSLY HARMED IF THE RATE OF INFLATION IN ISRAEL EXCEEDS
THE RATE OF DEVALUATION OF THE NIS AGAINST THE U.S. DOLLAR OR IF THE NIS IS
APPRECIATED AGAINST THE U.S. DOLLAR.
We generate substantially all of our revenues in dollars, but we incur a
significant portion of our expenses, principally salaries, related personnel
expenses and occupancy expenses in NIS. As a result, we are exposed to the risk
that our dollar costs in Israel will increase if the rate of inflation in Israel
will exceed the rate of devaluation of the NIS in relation to the dollar or that
the timing of this devaluation lags behind inflation in Israel or that the NIS
is appreciated against the dollar. Historically, over time, the NIS has been
devalued against the dollar, generally reflecting inflation rate differentials.
However, in 2007, the dollar depreciated against the NIS by nearly 9.0%, while
inflation increased by approximately 3.4%. As a result, our expenses increased
significantly in US dollar terms. Likewise, our operations could be adversely
affected if we are unable to protect ourselves against currency fluctuations in
the future.
In 2007, we entered into certain currency hedging transactions to decrease
the risk of financial exposure from fluctuations in the exchange rate of the
dollar against the NIS and we may enter into additionl currency hedging
transactions in the future. These measures, however, may not adequately protect
us from serious harm due to the impact of inflation in Israel.
IT MAY BE DIFFICULT TO ENFORCE A U.S. JUDGMENT AGAINST US, OUR OFFICERS AND
DIRECTORS OR TO ASSERT U.S. SECURITIES LAWS CLAIMS IN ISRAEL.
We are incorporated under the laws of the State of Israel. Service of
process upon us, our Israeli subsidiaries and our directors and officers,
substantially all of whom reside outside the United States, may be difficult to
obtain within the United States. Furthermore, because the majority of our assets
and investments, and substantially all of our directors and officers are located
outside the United States, any judgment obtained in the United States against us
or any of them may not be collectible within the United States.
19
We have been informed by our legal counsel in Israel, Goldfarb, Levy, Eran,
Meiri & Co., that it may be difficult to assert U.S. securities law claims in
original actions instituted in Israel. Israeli courts may refuse to hear a claim
based on a violation of U.S. securities laws because Israel is not the most
appropriate forum to bring such a claim. In addition, even if an Israeli court
agrees to hear a claim, it may determine that Israeli law and not U.S. law is
applicable to the claim. If U.S. law is found to be applicable, the content of
applicable U.S. law must be proved as a fact, which can be a time-consuming and
costly process. Certain matters of procedure will also be governed by Israeli
law. There is little binding case law in Israel addressing these matters.
Subject to specified time limitations and legal procedures, under the rules
of private international law currently prevailing in Israel, Israeli courts may
enforce a U.S. final judgment in a civil matter, including judgments based upon
the civil liability provisions of the U.S. securities laws and including a
monetary or compensatory judgment in a non-civil matter, provided that:
o the judgment is enforceable in the state in which it was given;
o adequate service of process has been effected and the defendant has
had a reasonable opportunity to present his arguments and evidence;
o the judgment and its enforcement are not contrary to the law, public
policy, security or sovereignty of the State of Israel;
o the judgment was not obtained by fraud and does not conflict with any
other valid judgment in the same matter between the same parties; and
o an action between the same parties in the same matter is not pending
in any Israeli court at the time the lawsuit is instituted in the U.S.
court.
WE DERIVE CERTAIN TAX BENEFITS UNDER ISRAELI LAW FROM OUR STATUS AS AN "APPROVED
ENTERPRISE", IN ADDITION TO OTHER TAX AND PROGRAM BENEFITS UNDER ISRAELI LAW.
SUCH BENEFITS MAY REQUIRE US TO SATISFY CERTAIN CONDITIONS, OR MAY BE REDUCED OR
ELIMINATED IN THE FUTURE. OUR POTENTIAL TAX LIABILITY COULD INCREASE IF WE FAIL
TO MEET SUCH CONDITIONS, OR IF SUCH PROGRAMS ARE REDUCED OR ELIMINATED.
Several of our capital investments have been granted "approved enterprise"
status under the Israeli Law for the Encouragement of Capital Investments, 1959,
or the Investments Law. An approved enterprise is eligible for tax benefits on
taxable income derived from its approved enterprise programs. The benefits
available to an approved enterprise are dependent upon the fulfillment of
conditions stipulated in applicable law and the certificate of approval. If we
fail to comply with these conditions, in whole or in part, with respect to any
approved enterprise program we establish, we may be required to pay additional
taxes for the period in which we benefited from the tax exemption or reduced tax
rates and we would likely be denied these benefits in the future. This could
harm our business and our profitability. In addition, the Israeli government may
reduce or eliminate in the future tax benefits available to approved enterprise
programs. Our approved enterprise program and the tax benefits thereunder may
not continue in the future at their current levels or at any level. The
termination or reduction of these tax benefits would likely increase our taxes.
SINCE WE RECEIVE GOVERNMENT GRANTS FOR RESEARCH AND DEVELOPMENT EXPENDITURES, WE
ARE SUBJECT TO ONGOING RESTRICTIONS AND CONDITIONS, INCLUDING RESTRICTIONS ON
OUR ABILITY TO MANUFACTURE PRODUCTS AND TRANSFER TECHNOLOGIES OUTSIDE OF ISRAEL.
SUCH GRANTS MAY BE TERMINATED OR REDUCED IN THE FUTURE, WHICH WOULD INCREASE OUR
COSTS.
We have received royalty-bearing grants from the Government of Israel
through the Office of the Chief Scientist of the Israeli Ministry of Industry,
Trade and Labor for the financing of a significant portion of our research and
development expenditures in Israel and we intend to apply for additional grants
in the future. To maintain our eligibility for these grants we must continue to
meet several conditions under the grant programs, including paying royalties
with respect to the grants received. If we fail to comply with any of the
conditions imposed by the Chief Scientist, we may be required to refund any
payments previously received, together with interest and penalties.
20
In addition, the terms of the Chief Scientist grants limit our ability to
manufacture products or transfer technologies, outside of Israel, if such
products or technologies were developed using know-how developed with or based
upon Chief Scientist grants. Any non-Israeli who becomes a holder of 5% or more
of our share capital is generally required to notify the Chief Scientist and to
undertake to observe the law governing the grant programs of the Chief
Scientist, the principal restrictions of which are the transferability limits
described above in this paragraph.
These programs may not continue in the future at their current levels or at
any level. From time to time, we may submit requests for new grants from the
Chief Scientist. These requests might not be approved, particularly in light of
the reduction in government spending in Israel. The termination or reduction of
these grants could materialy harm our financial condition and results of
operations.
21
RATIO OF EARNINGS TO FIXED CHARGES
The Company has no debt. Therefore, the ratio of earnings to fixed charges is
not being presented.
PRICE RANGE OF ORDINARY SHARES
NASDAQ GLOBAL MARKET
Our ordinary shares have been quoted on The Nasdaq Global Market under the
symbol "MTLK" since our initial public offering in December 2, 1999. Prior to
that time, there was no public market for our ordinary shares in the United
States. The following table sets forth, for the periods indicated, the high and
low last reported closing prices for our ordinary shares.
FIVE MOST RECENT YEARS HIGH LOW
---------------------- ---- ---
2003 $8.32 $2.74
2004 $9.05 $4.20
2005 $5.72 $3.85
2006 $6.49 $4.36
2007 $8.79 $4.43
EIGHT MOST RECENT QUARTERS AND SUBSEQUENT PERIOD
------------------------------------------------
Third Quarter 2006 $5.99 $5.13
Fourth Quarter 2006 $6.23 $5.10
First Quarter 2007 $6.76 $5.70
Second Quarter 2007 $6.67 $5.29
Third Quarter 2007 $8.79 $5.79
Fourth Quarter 2007 $6.79 $4.43
First Quarter 2008 $4.75 $1.85
Second Quarter 2008 $2.15 $1.03
MOST RECENT SIX MONTHS
----------------------
February 2008 $3.80 $2.72
March 2008 $3.03 $1.85
April 2008 $1.90 $1.71
May 2008 $2.15 $1.69
June 2008 $1.80 $1.03
July 2008 $0.98 $0.68
On August 22, 2008, the last reported sale price of our ordinary shares on
NASDAQ was $1.01 per ordinary share.
22
TEL AVIV STOCK EXCHANGE
Our ordinary shares have been listed on the Tel-Aviv Stock Exchange, or
TASE, since December 3, 2000. The table below sets forth the high and low last
reported prices of our ordinary shares (in NIS and dollars) on the TASE. The
translation into dollars is based on the daily representative rate of exchange
published by the Bank of Israel.
HIGH LOW
---------------- -----------------
FIVE MOST RECENT YEARS $ NIS $ NIS
---------------------- ---- ----- ---- ------
2003 8.48 38.39 2.55 12.11
2004 9.37 41.03 4.09 18.24
2005 5.81 25.31 3.93 17.71
2006 6.42 28.48 4.40 20.77
2007 8.50 36.06 4.41 17.29
EIGHT MOST RECENT QUARTERS AND SUBSEQUENT PERIOD
------------------------------------------------
Third Quarter 2006 6.03 26.47 5.13 22.12
Fourth Quarter 2006 6.26 26.30 5.22 22.25
First Quarter 2007 6.78 28.41 5.62 23.75
Second Quarter 2007 7.08 29.29 5.38 22.30
Third Quarter 2007 8.50 36.06 5.44 23.11
Fourth Quarter 2007 6.96 27.29 4.41 17.29
First Quarter 2008 4.80 18.47 1.81 6.42
Second Quarter 2008 2.11 7.09 1.01 3.39
MOST RECENT SIX MONTHS
----------------------
February 2008 3.99 14.34 2.74 9.91
March 2008 2.91 10.58 1.81 6.42
April 2008 1.98 7.04 1.72 5.91
May 2008 2.11 7.09 1.71 5.86
June 2008 1.77 5.72 1.01 3.39
July 2008 1.16 4.06 0.74 2.45
On August 24, 2008, the last reported price of our ordinary shares on the
TASE was NIS 3.63 (or $1.04, based on the representative rate of exchange
published by the Bank of Israel on August 24, 2008) per share.
23
CAPITALIZATION AND INDEBTEDNESS
The following table sets forth our capitalization as of December 31, 2007.
You should read this table together with the audited consolidated financial
statements and the notes thereto and our supplemental financial data
incorporated by reference in this prospectus.
AS OF
DECEMBER 31, 2007
---------------
U.S. DOLLARS IN
THOUSANDS
Short-term indebtedness --
Long-term indebtedness --
Total shareholders' equity 28,331
Total capitalization 28,331
------
DIVIDEND POLICY
We have never declared or paid any cash dividends on our ordinary shares.
We do not anticipate paying any cash dividends on our ordinary shares in the
foreseeable future. We currently intend to retain all future earnings for use in
the development of our business.
USE OF PROCEEDS
Unless we state otherwise in the applicable prospectus supplement, we
expect to use the net proceeds from the sale of the securities in connection
with our strategic plan, including marketing expenses, research and development
expenses, general and administrative expenses and for working capital and other
general corporate purposes, including investments and acquisitions. We may
invest funds that we do not immediately require in marketable securities.
DESCRIPTION OF ORDINARY SHARES
DESCRIPTION OF ORDINARY SHARES
Our registered share capital consists of a single class of 50,000,000
ordinary shares, par value NIS 0.10 per share.
All issued and outstanding ordinary shares are fully paid and
non-assessable. Our ordinary shares confer upon our shareholders the right to
receive notices of, and to attend, shareholder meetings, the right to one vote
per ordinary share at all shareholders' meetings for all purposes, and to share
equally, on a per share basis, in such dividends as may be declared by our board
of directors; and upon liquidation or dissolution, the right to participate in
the distribution of any surplus assets of the Company legally available for
distribution to shareholders after payment of all debts and other liabilities of
the Company. All ordinary shares rank pari passu in all respects with each
other. Our board of directors may, from time to time, make such calls as it may
think fit upon a shareholder in respect of any sum unpaid in respect of shares
held by such shareholder which is not payable at a fixed time, and each
shareholder shall pay the amount of every call so made upon him (and of each
installment thereof if the same is payable in installments).
24
As of December 31, 2007, we had outstanding 23,478,732 ordinary shares, and
employee stock options to purchase an aggregate of 4,325,398 ordinary shares at
a weighted average exercise price of $6.41, with the latest expiration date of
these options being May 24, 2025 (of which options to purchase an aggregate of
2,344,223 ordinary shares were exercisable as of December 31, 2007). As of July
31, 2008, we had outstanding 23,490,732 ordinary shares. Our shareholders do not
have preemptive rights.
From February 1, 2007 through August 1, 2008, we issued a total of
3,735,406 ordinary shares, of which (1) 3,200,000 shares were issued in
connection with a private placement that closed on August 8, 2007, in
consideration for an aggregate of $19.2 million, or $6.00 per share, and (2)
535,406 shares were issued upon the exercise of options granted under our share
option plans. From time to time during the three years preceding the date of
this prospectus, we have issued ordinary shares as a result of exercises of
options granted under our share option plans.
The transfer agent and registrar for our ordinary shares is American Stock
Transfer & Trust Company, 59 Maiden Lane, New York, New York 10007.
DUTIES OF SHAREHOLDERS
Under the Israeli Companies Law, 5759-1999, or the Companies Law, a
shareholder has a duty to act in good faith towards the Company and other
shareholders and to refrain from abusing his or her power in the company
including, among other things, voting in a general meeting of shareholders on
the following matters:
o any amendment to the articles of association;
o an increase of the company's authorized share capital;
o a merger; or
o approval of interested party transactions which require shareholder
approval.
In addition, any controlling shareholder, any shareholder who knows that it
possesses power to determine the outcome of a shareholder vote and any
shareholder who, pursuant to the provisions of a company's articles of
association, has the power to appoint or prevent the appointment of an office
holder in the company, is under a duty to act with fairness towards the company.
The Companies Law does not describe the substance of this duty but provides that
a breach of his duty is tantamount to a breach of fiduciary duty of an officer
of the Company.
MEETINGS OF SHAREHOLDERS
An annual general meeting of our shareholders shall be held once in every
calendar year at such time and at such place either within or without the State
of Israel as may be determined by our board of directors.
Our board of directors may, whenever it thinks fit, convene a special
general meeting at such time and place, within or without the State of Israel,
as may be determined by the board of directors. Special general meetings may
also be convened upon requisition in accordance with the Companies Law.
RIGHT OF NON-ISRAELI STOCKHOLDERS TO VOTE
Our ordinary shares may be freely held and traded pursuant to the General
Permit and the Currency Control Law. The ownership or voting of ordinary shares
by non-residents of Israel, except with respect to citizens of countries that
are in a state of war with Israel, are not restricted in any way by our
memorandum of association or articles of association or by the laws of the State
of Israel.
25
MERGERS AND ACQUISITIONS
There are no specific provisions of our Memorandum or Articles of
Association that would have an effect of delaying, deferring or preventing a
change in control of us or that would operate only with respect to a merger,
acquisition or corporate restructuring involving us (or any of our
subsidiaries). However, certain provisions of the Companies Law may have such
effect.
A merger of the Company shall require the approval of the holders of a
majority of the voting power represented at the annual or special general
meeting in person or by proxy or by written ballot, as shall be permitted, and
voting thereon in accordance with the provisions of the Companies Law. Upon the
request of a creditor of either party of the proposed merger, the court may
delay or prevent the merger if it concludes that there exists a reasonable
concern that as a result of the merger, the surviving company will be unable to
satisfy the obligations of any of the parties to the merger. In addition, a
merger may not be completed unless at least (i) 50 days have passed from the
time that the requisite proposal for the merger has been filed by each party
with the Israeli Registrar of Companies and (ii) 30 days have passed since the
merger was approved by the shareholders of each party.
The Companies Law also provides that an acquisition of shares of a public
company must be made by means of a tender offer if as a result of the
acquisition the purchaser would become a 25% or greater shareholder of the
company and there is no existing 25% or greater shareholder in the company. An
acquisition of shares of a public company must be made by means of a tender
offer if as a result of the acquisition the purchaser would become a 45% or
greater shareholder of the company and there is no existing 45% or greater
shareholder in the company. These requirements do not apply if the acquisition
(i) occurs in the context of a private placement by the company that received
shareholder approval, (ii) was from a 25% shareholder of the company and
resulted in the acquirer becoming a 25% shareholder of the company or (iii) was
from a 45% shareholder of the company and resulted in the acquirer becoming a
45% shareholder of the company. The tender offer must be extended to all
shareholders, but the offerer is not required to purchase more than 5% of the
company's outstanding shares, regardless of how many shares are tendered by
shareholders. The tender offer may be consummated only if (i) at least 5% of the
company's outstanding shares will be acquired by the offerer and (ii) the number
of shares tendered in the offer exceeds the number of shares whose holders
objected to the offer.
If as a result of an acquisition of shares the acquirer will hold more than
90% of a company's outstanding shares, the acquisition must be made by means of
a tender offer for all of the outstanding shares. If as a result of a full
tender offer the acquirer would own more than 95% of the outstanding shares,
then all the shares that the acquirer offered to purchase will be transferred to
it. The law provides for appraisal rights if any shareholder files a request in
court within three months following the consummation of a full tender offer. If
as a result of a full tender offer the acquirer would own 95% or less of the
outstanding shares, then the acquirer may not acquire shares that will cause his
shareholding to exceed 90% of the outstanding shares.
DESCRIPTION OF PURCHASE CONTRACTS
We may issue purchase contracts for the purchase or sale of equity
securities issued by the Company under this prospectus or any combination
thereof as specified in the applicable prospectus supplement.
Each purchase contract will entitle the holder thereof to purchase or sell,
and obligate us to sell or purchase, on specified dates, such securities at a
specified purchase price, which may be based on a formula, all as set forth in
the applicable prospectus supplement. We may, however, satisfy our obligations,
if any, with respect to any purchase contract by delivering the cash value of
such purchase contract or the cash value of the property otherwise deliverable,
as set forth in the applicable prospectus supplement. The applicable prospectus
supplement will also specify the methods by which the holders may purchase or
sell such securities and any acceleration, cancellation or termination
provisions or other provisions relating to the settlement of a purchase
contract.
The purchase contracts may require us to make periodic payments to the
holders thereof or vice versa, which payments may be deferred to the extent set
forth in the applicable prospectus supplement, and those payments may be
unsecured or prefunded on some basis. The purchase contracts may require the
holders thereof to secure their obligations in a specified manner to be
described in the applicable prospectus supplement. Alternatively, purchase
contracts may require holders to satisfy their obligations thereunder when the
purchase contacts are issued. Our obligation to settle such pre-paid purchase
contacts on the relevant settlement date may constitute indebtedness.
26
DESCRIPTION OF UNITS
We may, from time to time, issue units comprised of one or more of the
other securities that may be offered under this prospectus, in any combination.
Each unit will be issued so that the holder of the unit is also the holder of
each security included in the unit. Thus, the holder of a unit will have the
rights and obligations of a holder of each included security. The unit agreement
under which a unit is issued may provide that the securities included in the
unit may not be held or transferred separately at any time, or at any time
before a specified date.
Any applicable prospectus supplement will describe:
o the material terms of the units and of the securities comprising the
units, including whether and under what circumstances those securities
may be held or transferred separately;
o any material provisions relating to the issuance, payment, settlement,
transfer or exchange of the units or of the securities comprising the
units; and
o any material provisions of the governing unit agreement that differ
from those described above.
DESCRIPTION OF WARRANTS
We may issue warrants to purchase equity securities issued by the Company
under this prospectus. Warrants may be issued independently or together with any
other securities issued by the Company under this prospectus and may be attached
to, or separate from, such securities. Each series of warrants will be issued
under a separate warrant agreement to be entered into between us and a warrant
agent. The terms of any warrants to be issued and a description of the material
provisions of the applicable warrant agreement will be set forth in the
applicable prospectus supplement.
The applicable prospectus supplement will describe the following terms of
any warrants in respect of which this prospectus is being delivered:
o the title of such warrants;
o the aggregate number of such warrants;
o the price or prices at which such warrants will be issued;
o the currency or currencies, in which the price of such warrants will
be payable;
o the securities purchasable upon exercise of such warrants;
o the date on which the right to exercise such warrants shall commence
and the date on which such right shall expire;
o if applicable, the minimum or maximum amount of such warrants which
may be exercised at any one time;
o if applicable, the designation and terms of the securities with which
such warrants are issued and the number of such warrants issued with
each such security;
o if applicable, the date on and after which such warrants and the
related securities will be separately transferable;
27
o information with respect to book-entry procedures, if any;
o any material Israeli and U.S. federal income tax consequences;
o the antidilution provisions of the warrants; and
o any other terms of such warrants, including terms, procedures and
limitations relating to the exchange and exercise of such warrants.
TAXATION
The material Israeli and U.S. federal income tax consequences relating to
the purchase, ownership and disposition of any of the securities offered by this
prospectus will be set forth in the prospectus supplement offering those
securities.
PLAN OF DISTRIBUTION
We may sell the ordinary shares, purchase contracts, units or warrants,
which are referred to collectively as "our securities," in any one or more of
the following ways from time to time:
o to or through underwriters;
o to or through dealers;
o through agents; or
o directly to purchasers, including our affiliates.
The prospectus supplement with respect to any offering of our securities
will set forth the terms of the offering, including:
o the name or names and addresses of any underwriters, dealers or
agents;
o the purchase price of the securities and the proceeds to us from the
sale;
o any underwriting discounts and commissions or agency fees and other
items constituting underwriters' or agents' compensation; and
o any delayed delivery arrangements.
The distribution of the securities may be effected from time to time in one
or more transactions at a fixed price or prices, which may be changed, at market
prices prevailing at the time of sale, at prices related to the prevailing
market prices or at negotiated prices.
If securities are sold by means of an underwritten offering, we will
execute an underwriting agreement with an underwriter or underwriters, and the
names of the specific managing underwriter or underwriters, as well as any other
underwriters, and the terms of the transaction, including commissions, discounts
and any other compensation of the underwriters and dealers, if any, will be set
forth in the prospectus supplement which will be used by the underwriters to
sell the securities. If underwriters are utilized in the sale of the securities,
the securities will be acquired by the underwriters for their own account and
may be resold from time to time in one or more transactions, including
negotiated transactions, at fixed public offering prices or at varying prices
determined by the underwriters at the time of sale.
28
Our securities may be offered to the public either through underwriting
syndicates represented by managing underwriters or directly by the managing
underwriters. If any underwriter or underwriters are utilized in the sale of the
securities, unless otherwise indicated in the prospectus supplement, the
underwriting agreement will provide that the obligations of the underwriters are
subject to conditions precedent and that the underwriters with respect to a sale
of securities will be obligated to purchase all of those securities if they
purchase any of those securities.
We may grant to the underwriters options to purchase additional securities
to cover over-allotments, if any, at the public offering price with additional
underwriting discounts or commissions. If we grant any over-allotment option,
the terms of any over-allotment option will be set forth in the prospectus
supplement relating to those securities.
If a dealer is utilized in the sales of securities in respect of which this
prospectus is delivered, we will sell those securities to the dealer as
principal. The dealer may then resell those securities to the public at varying
prices to be determined by the dealer at the time of resale. Any reselling
dealer may be deemed to be an underwriter, as the term is defined in the
Securities Act of the securities so offered and sold. The name of the dealer and
the terms of the transaction will be set forth in the related prospectus
supplement.
Offers to purchase securities may be solicited by agents designated by us
from time to time. Any agent involved in the offer or sale of the securities in
respect of which this prospectus is delivered will be named, and any commissions
payable by us to the agent will be set forth, in the applicable prospectus
supplement. Unless otherwise indicated in the prospectus supplement, any agent
will be acting on a reasonable best efforts basis for the period of its
appointment. Any agent may be deemed to be an underwriter, as that term is
defined in the Securities Act of the securities so offered and sold.
Offers to purchase securities may be solicited directly by us and the sale
of those securities may be made by us directly to institutional investors or
others, who may be deemed to be underwriters within the meaning of the
Securities Act with respect to any resale of those securities. The terms of any
sales of this type will be described in the related prospectus supplement.
We also may sell directly to investors through subscription rights
distributed to our shareholders on a pro rata basis. In connection with any
distribution of subscription rights to shareholders, if all of the underlying
securities are not subscribed for, we may sell the unsubscribed securities
directly to third parties or may engage the services of one or more
underwriters, dealers or agents, including standby underwriters, to sell the
unsubscribed securities to third parties.
Underwriters, dealers, agents and remarketing firms may be entitled under
relevant agreements entered into with us to indemnification by us against
certain civil liabilities, including liabilities under the Securities Act, that
may arise from any untrue statement or alleged untrue statement of a material
fact or any omission or alleged omission to state a material fact in this
prospectus, any supplement or amendment hereto, or in the registration statement
of which this prospectus forms a part, or to contribution with respect to
payments which the agents, underwriters or dealers may be required to make.
If so indicated in the prospectus supplement, we will authorize
underwriters or other persons acting as our agents to solicit offers by
institutions to purchase securities from us pursuant to contracts providing for
payments and delivery on a future date. Institutions with which contracts of
this type may be made include commercial and savings banks, insurance companies,
pension funds, investment companies, educational and charitable institutions and
others, but in all cases those institutions must be approved by us. The
obligations of any purchaser under any contract of this type will be subject to
the condition that the purchase of the securities shall not at the time of
delivery be prohibited under the laws of the jurisdiction to which the purchaser
is subject. The underwriters and other persons acting as our agents will not
have any responsibility in respect of the validity or performance of those
contracts.
One or more firms, referred to as "remarketing firms," may also offer or
sell the securities, if the prospectus supplement so indicates, in connection
with a remarketing arrangement upon their purchase. Remarketing firms will act
as principals for their own accounts or as agents for Metalink or any of its
subsidiaries. These remarketing firms will offer or sell the securities in
accordance with a redemption or repayment pursuant to the terms of the
securities.
29
The prospectus supplement will identify any remarketing firm and the terms
of its agreement, if any, with Metalink or any of its subsidiaries and will
describe the remarketing firm's compensation. Remarketing firms may be deemed to
be underwriters in connection with the securities they remarket. Remarketing
firms may be entitled under agreements that may be entered into with Metalink or
any of its subsidiaries to indemnification by Metalink or any of its
subsidiaries against certain civil liabilities, including liabilities under the
Securities Act, and may engage in transactions with or perform services for
Metalink or any of its subsidiaries in the ordinary course of business.
Disclosure in the prospectus supplement of our use of delayed delivery
contracts will include the commission that underwriters and agents soliciting
purchases of the securities under delayed contracts will be entitled to receive
in addition to the date when we will demand payment and delivery of the
securities under the delayed delivery contracts. These delayed delivery
contracts will be subject only to the conditions that we describe in the
prospectus supplement.
In connection with the offering of securities, persons participating in the
offering, such as any underwriters, may purchase and sell securities in the open
market. These transactions may include over-allotment and stabilizing
transactions and purchases to cover syndicate short positions created in
connection with the offering. Stabilizing transactions consist of bids or
purchases for the purpose of preventing or retarding a decline in the market
price of the securities, and syndicate short positions involve the sale by
underwriters of a greater number of securities than they are required to
purchase from any issuer in the offering. Underwriters also may impose a penalty
bid, whereby selling concessions allowed to syndicate members or other
broker-dealers in respect of the securities sold in the offering for their
account may be reclaimed by the syndicate if the securities are repurchased by
the syndicate in stabilizing or covering transactions. These activities may
stabilize, maintain or otherwise affect the market price of the securities,
which may be higher than the price that might prevail in the open market, and
these activities, if commenced, may be discontinued at any time.
EXPERTS
Our consolidated financial statements as at December 31, 2006 and December
31, 2007 and for each of the years ended December 31, 2007, 2006 and 2005
appearing in our Annual Report on Form 20-F filed with the SEC on June 30, 2008
and incorporated by reference herein have been audited by Brightman Almgor &
Co., a member of Deloitte Touche Tohmatsu, independent registered public
accounting firm, as indicated in their report with respect thereto, which is
incorporated by reference herein. Such financial statements are incorporated by
reference in reliance upon the report of such firm given upon their authority as
experts in auditing and accounting.
LEGAL MATTERS
Certain legal matters with respect to Israeli law with respect to the
validity of the offered securities will be passed upon for the us by Goldfarb,
Levy, Eran, Meiri, Tzafrir & Co., Tel-Aviv, Israel. Any underwriters will be
advised with respect to other issues relating to any offering by their own legal
counsel.
WHERE YOU CAN FIND MORE INFORMATION
This prospectus is part of a registration statement that we filed with the
SEC. The registration statement, including the attached exhibits, contains
additional relevant information about us. The rules and regulations of the SEC
allow us to omit some of the information included in the registration statement
from this prospectus. In addition, we file annual and special reports and other
information with the SEC. You may read and copy such material at the public
reference facilities maintained by the SEC at Room 1024, 100 F Street, N.E.,
Washington, D.C. 20549, as well as at the SEC's regional offices. You may also
obtain copies of such material from the SEC at prescribed rates by wiring to the
Public Reference Section of the SEC, 100 F Street, N.E., Washington, D.C. 20549.
Please call the SEC at 1-800-SEC-0330 for further information on the public
reference rooms.
The SEC maintains an Internet website at http://www.sec.gov that contains
reports, proxy, information statements and other material that are filed through
the SEC's Electronic Data Gathering, Analysis and Retrieval ("EDGAR") system and
file electronically with the SEC.
30
Our ordinary shares are quoted on the Nasdaq Global Market under the symbol
"MTLK." You may inspect certain reports and other information concerning us at
the offices of the National Association of Securities Dealers, Inc., 1735 K
Street, N.W., Washington, D.C. 20006.
Information about us is also available on our website at
http://www.mtlk.com. SUCH INFORMATION ON OUR WEBSITE IS NOT PART OF THIS
PROSPECTUS.
INCORPORATION OF CERTAIN INFORMATION BY REFERENCE
The SEC allows us to "incorporate by reference" information that we file
with them, which means that we can disclose important information to you by
referring you to those documents. The information incorporated by reference is
an important part of this prospectus, and information that we file later with
the SEC will automatically update and supersede this information. We incorporate
by reference the documents listed below and any future filings we will make with
the SEC under Section 13(a), 13(c), 14 or 15(d) of the Securities Exchange Act
of 1934:
The following documents filed with the SEC are incorporated in this
prospectus by reference:
o Our Annual Report on Form 20-F for the year ended December 31, 2007
(File No. 0-30394), filed June 30, 2008;
o Our Report on Form 6-K, filed August 18, 2008;
o Our Report on Form 6-K, filed July 28, 2008;
o Any future reports on Form 6-K to the extent that we indicate they are
incorporated by reference into this registration statement;
o Any future annual reports on Form 20-F that we may file with the SEC
under the Exchange Act, prior to the termination of any offering
contemplated by the prospectus; and
o The description of our ordinary shares contained in our Registration
Statement on Form 8-A, filed with the SEC on November 29, 1999,
including any other amendment or report filed for the purpose of
updating such description.
We filed a registration statement on Form F-3 to register with the SEC the
securities described in this prospectus. This prospectus is part of that
registration statement. As permitted by SEC rules, this prospectus does not
contain all of the information included in the registration statement and the
accompanying exhibits and schedules we file with the SEC. You may refer to the
registration statement and the exhibits and schedules for more information about
us and our securities. The registration statement and exhibits and schedules are
also available at the SEC's Public Reference Room or through its web site.
We will provide to each person, including any beneficial owner, to whom
this prospectus is delivered, a copy of these filings, at no cost, upon written
or oral request to us at the following address:
Metalink Ltd.
Yakum Business Park, Yakum 60972, Israel
Tel. (972)(9) 960-5555
Attn.: Corporate Secretary
You should rely only on the information contained or incorporated in this
prospectus or any supplement. We have not authorized anyone else to provide you
with different information. You should not rely on any other representations.
Our affairs may change after this prospectus or any supplement is distributed.
You should not assume that the information in this prospectus or any supplement
is accurate as of any date other than the date on the front of those documents.
You should read all information supplementing this prospectus.
31
ENFORCEMENT OF CIVIL LIABILITIES
Service of process upon us and upon our directors and officers and the
Israeli experts named in this prospectus, a substantial number of whom reside
outside the United States, may be difficult to obtain within the United States.
Furthermore, because our principal assets and a substantial number of our
directors and officers are located outside the United States, any judgment
obtained in the United States against us or any of our directors and officers
may not be collectible within the United States.
We have been informed by our legal counsel in Israel, Goldfarb, Levy, Eran,
Meiri, Tzafrir & Co., that there is doubt concerning the enforceability of civil
liabilities under the Securities Act and the Exchange Act in original actions
instituted in Israel. However, subject to specified time limitations, Israeli
courts may enforce a United States final executory judgment in a civil matter,
including a monetary or compensatory judgment in a non-civil matter, obtained
after due process before a court of competent jurisdiction according to the laws
of the state in which the judgment is given and the rules of private
international law currently prevailing in Israel. The rules of private
international law currently prevailing in Israel do not prohibit the enforcement
of a judgment by Israeli courts provided that:
o the judgment is enforceable in the state in which it was given;
o adequate service of process has been effected and the defendant has
had a reasonable opportunity to present his arguments and evidence;
o the judgment and the enforcement of the judgment are not contrary to
the law, public policy, security or sovereignty of the state of
Israel;
o the judgment was not obtained by fraud and does not conflict with any
other valid judgment in the same matter between the same parties; and
o an action between the same parties in the same matter is not pending
in any Israeli court at the time the lawsuit is instituted in the
foreign court.
We have irrevocably appointed Metalink Inc. as our agent to receive service
of process in any action against us in any U.S. jurisdiction arising out of this
offering or any purchase or sale of securities in connection with this offering.
If a foreign judgment is enforced by an Israeli court, it generally will be
payable in Israeli currency, which can then be converted into non-Israeli
currency and transferred out of Israel. The usual practice in an action before
an Israeli court to recover an amount in a non-Israeli currency is for the
Israeli court to issue a judgment for the equivalent amount in Israeli currency
at the rate of exchange in force on the date of the judgment, but the judgment
debtor may make payment in foreign currency. Pending collection, the amount of
the judgment of an Israeli court stated in Israeli currency ordinarily will be
linked to the Israeli consumer price index plus interest at an annual statutory
rate set by Israeli regulations prevailing at the time. Judgment creditors must
bear the risk of unfavorable exchange rates.
EXPENSES
The following is a statement of expenses in connection with the
distribution of the securities registered. All amounts shown are estimates
except the SEC registration fee.
Securities and Exchange Commission registration fee U.S.$ 982.50
Legal fees and expenses U.S.$ 25,000.00
Accounting fees and expenses U.S.$ 5,000.00
Printing expenses U.S.$ 3,000.00
Miscellaneous expenses U.S.$ 1,000.00
--------------------
Total U.S.$ 34,982.50
====================
32
PART II.
INFORMATION NOT REQUIRED IN PROSPECTUS
ITEM 8. INDEMNIFICATION OF DIRECTORS AND OFFICERS
EXCULPATION OF OFFICE HOLDERS
Under the Israeli Companies Law, an Israeli company may not exempt an
office holder from liability with respect to a breach of his duty of loyalty,
but may exempt in advance an office holder from his liability to the company, in
whole or in part, with respect to a breach of his duty of care (except in
connection with distributions), provided that the articles of association of the
company allow it to do so. Our articles of association allow us to exempt our
office holders to the fullest extent permitted by law.
OFFICE HOLDER INSURANCE
Our articles of association provide that, subject to the provisions of the
Israeli Companies Law, we may enter into a contract for the insurance of the
liability of any of our office holders with respect to an act performed in the
capacity of an office holder for:
o a breach of his duty of care to us or to another person;
o a breach of his duty of loyalty to us, provided that the office holder
acted in good faith and had reasonable cause to assume that his act
would not prejudice our interests; or
o a financial liability imposed upon him in favor of another person.
INDEMNIFICATION OF OFFICE HOLDERS
Subject to certain qualifications, the Israeli Companies Law also permits
us to indemnify an office holder for acts or omissions committed in his or her
capacity as an office holder of the company for:
o a financial liability imposed on him in favor of another person by any
judgement, including a settlement or an arbitrator's award approved by
a court. Such indemnification may be approved (i) after the liability
has been incurred, or (ii) in advance, provided that our undertaking
to indemnify is limited to events that our board of directors believes
are foreseeable in light of our actual operations at the time of
providing the undertaking and to a sum or criterion that our board of
directors determines to be reasonable under the circumstances;
o reasonable litigation expenses, including attorneys' fees, expended by
the office holder as a result of an investigation or proceeding
instituted against him by a competent authority, provided that such
investigation or proceeding concluded without the filing of an
indictment against him and either (i) concluded without the imposition
of any financial liability in lieu of criminal proceedings, or (ii)
concluded with the imposition of a financial liability in lieu of
criminal proceedings but relates to a criminal offense that does not
require proof of criminal intent; and
o reasonable litigation expenses, including attorneys' fees, expended by
the office holder or charged to him or her by a court, resulting from
the following: proceedings we institute against him or her or
instituted on our behalf or by another person; a criminal indictment
from which he or she was acquitted; or a criminal indictment in which
he or she was convicted for a criminal offense that does not require
proof of intent.
II-1
LIMITATIONS ON INSURANCE AND INDEMNIFICATION
The Israeli Companies Law provides that a company may not exculpate or
indemnify an office holder nor enter into an insurance contract, which would
provide coverage for any monetary liability incurred as a result of any of the
following:
o a breach by the office holder of his duty of loyalty unless, with
respect to insurance coverage or indemnification, the office holder
acted in good faith and had a reasonable basis to believe that the act
would not prejudice the company;
o a breach by the office holder of his duty of care if the breach was
done intentionally or recklessly, unless the breach was done
negligently;
o any act or omission done with the intent to derive an illegal personal
benefit; or
o any fine levied against the office holder.
Under the Israeli Companies Law, an undertaking to indemnify or
indemnification of, exculpation of, and procurement of insurance coverage for,
our office holders must be approved by our audit committee and our board of
directors and, in specified circumstances, also by our shareholders.
We have obtained director's and officer's liability insurance with an
aggregate coverage limit of $5 million. In addition we entered into
indemnification and exculpation agreements with our directors and executive
officers in accordance with our articles of association.
II-2
ITEM 9. EXHIBITS
NUMBER DESCRIPTION
------ ----------------------------------------------------------------------
1 Form of Underwriting Agreement.*
3.1 Memorandum of Association, as amended (English translation accompanied
by Hebrew original), filed as Exhibit 4.1 to the Registrant's
Registration Statement on Form S-8, filed with the SEC on March 12,
2008, and incorporated herein by reference.
3.2 Articles of Association of the Registrant, as amended and restated,
filed as Exhibit 4.3 to the Registrant's Registration Statement on
Form S-8, filed with the SEC on April 17, 2001, and as Exhibit 4.2 to
the Registrant's Registration Statement on Form S-8, filed with the
SEC on March 12, 2008, and incorporated herein by reference.
4.1 Form of Ordinary Share Certificate Filed as Exhibit 4 to the
Registrant's Registration Statement on Form F-1, filed with the SEC on
November 10, 1999, and incorporated herein by reference.
4.2 Form of Purchase Contract Agreement (including form of Purchase
Contract Certificate).*
4.3 Form of Unit Agreement (including form of Unit Certificate).*
4.4 Form of Warrant Agreement (including form of Warrant Certificate).*
5.1 Opinion of Goldfarb, Levy, Eran, Meiri, Tzafrir & Co., Israeli counsel
to the Registrant. **
23.1 Consent of Brightman Almgor & Co., a member of Deloitte Touche
Tohmatsu.
23.2 Consent of Goldfarb, Levy, Eran, Meiri, Tzafrir & Co. (included in 5.1
above). **
24 Powers of attorney (included in the signature pages herein).**
----------
* If applicable, to be filed by amendment or incorporated by reference pursuant
to a report on Form 6-K.
** Previously filed.
ITEM 10. UNDERTAKINGS
(a) The undersigned Registrant hereby undertakes:
(1) To file, during any period in which offers or sales are being
made, a post-effective amendment to this registration statement;
(i) To include any prospectus required by Section 10(a)(3) of the
Securities Act of 1933, as amended;
II-3
(ii) To reflect in the prospectus any facts or events arising
after the effective date of the registration statement (or the most
recent post-effective amendment thereof) which, individually or in the
aggregate, represent a fundamental change in the information set forth
in the registration statement. Notwithstanding the foregoing, any
increase or any decrease in volume of securities offered (if the total
dollar value of securities offered would not exceed that which was
registered) and any deviation from the low or high end of the
estimated maximum offering range may be reflected in the form of
prospectus filed with the SEC pursuant to Rule 424(b) if, in the
aggregate, the changes in volume and price represent no more than 20
percent change in the maximum aggregate offering price set forth in
the "Calculation of Registration Fee" table in the effective
registration statement; and
(iii) To include any material information with respect to the
plan of distribution not previously disclosed in the registration
statement or any material change to such information in the
registration statement;
PROVIDED, HOWEVER, that paragraphs (a)(1)(i) and (a)(1)(ii) do
not apply if the registration statement is on Form S-3, Form S-8 or
Form F-3, and the information required to be included in a
post-effective amendment by those paragraphs is contained in periodic
reports filed with or furnished to the SEC by the Registrant pursuant
to Section 13 or Section 15(d) of the Securities Exchange Act of 1934,
as amended, that are incorporated by reference in the registration
statement.
(2) That, for the purpose of determining any liability under the
Securities Act of 1933, as amended, each such post-effective amendment
shall be deemed to be a new registration statement relating to the
securities offered therein, and the offering of such securities at that
time shall be deemed to be the initial BONA FIDE offering thereof.
(3) To remove from registration by means of a post-effective amendment
any of the securities being registered which remain unsold at the
termination of the offering.
(4) To file a post-effective amendment to the registration statement
to include any financial statements required by Item 8.A. of Form 20-F at
the start of any delayed offering or throughout a continuous offering.
Financial statements and information otherwise required by Section 10(a)(3)
of the Securities Act of 1933, as amended, need not be furnished, PROVIDED,
that the Registrant includes in the prospectus, by means of a
post-effective amendment, financial statements required pursuant to this
paragraph (a)(4) and other information necessary to ensure that all other
information in the prospectus is at least as current as the date of those
financial statements. Notwithstanding the foregoing, with respect to
registration statements on Form F-3, a post-effective amendment need not be
filed to include financial statements and information required by Section
10(a)(3) of the Securities Act of 1933, as amended, or Rule 3-19 of
Regulation S-K if such financial statements and information are contained
in periodic reports filed with or furnished to the SEC by the registrant
pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of
1934, as amended, that are incorporated by reference in this Form F-3.
(5) That, for the purpose of determining liability under the
Securities Act of 1933 to any purchaser:
(i) If the Registrant is relying on Rule 430B:
(A) Each prospectus filed by the registrant pursuant to Rule
424(b)(3) shall be deemed to be part of the registration
statement as of the date the filed prospectus was deemed part of
and included in the registration statement; and
(B) Each prospectus required to be filed pursuant to Rule
424(b)(2), (b)(5), or (b)(7) as part of a registration statement
in reliance on Rule 430B relating to an offering made pursuant to
Rule 415(a)(1)(i), (vii), or (x) for the purpose of providing the
information required by section 10(a) of the Securities Act of
1933 shall be deemed to be part of and included in the
registration statement as of the earlier of the date such form of
prospectus is first used after effectiveness or the date of the
first contract of sale of securities in the offering described in
the prospectus. As provided in Rule 430B, for liability purposes
of the issuer and any person that is at that date an underwriter,
such date shall be deemed to be a new effective date of the
registration statement relating to the securities in the
registration statement to which that prospectus relates, and the
offering of such securities at that time shall be deemed to be
the initial bona fide offering thereof. Provided, however, that
no statement made in a registration statement or prospectus that
is part of the registration statement or made in a document
incorporated or deemed incorporated by reference into the
registration statement or prospectus that is part of the
registration statement will, as to a purchaser with a time of
contract of sale prior to such effective date, supersede or
modify any statement that was made in the registration statement
or prospectus that was part of the registration statement or made
in any such document immediately prior to such effective date; or
II-4
(ii) If the registrant is subject to Rule 430C, each prospectus
filed pursuant to Rule 424(b) as part of a registration statement
relating to an offering, other than registration statements relying on
Rule 430B or other than prospectuses filed in reliance on Rule 430A,
shall be deemed to be part of and included in the registration
statement as of the date it is first used after effectiveness.
Provided, however, that no statement made in a registration statement
or prospectus that is part of the registration statement or made in a
document incorporated or deemed incorporated by reference into the
registration statement or prospectus that is part of the registration
statement will, as to a purchaser with a time of contract of sale
prior to such first use, supersede or modify any statement that was
made in the registration statement or prospectus that was part of the
registration statement or made in any such document immediately prior
to such date of first use.
(6) That, for the purpose of determining liability of the registrant
under the Securities Act of 1933 to any purchaser in the initial
distribution of the securities: The undersigned Registrant undertakes that
in a primary offering of securities of the undersigned Registrant pursuant
to this registration statement, regardless of the underwriting method used
to sell the securities to the purchaser, if the securities are offered or
sold to such purchaser by means of any of the following communications, the
undersigned Registrant will be a seller to the purchaser and will be
considered to offer or sell such securities to such purchaser:
(i) Any preliminary prospectus or prospectus of the undersigned
Registrant relating to the offering required to be filed pursuant to
Rule 424;
(ii) Any free writing prospectus relating to the offering
prepared by or on behalf of the undersigned Registrant or used or
referred to by the undersigned Registrant;
(iii) The portion of any other free writing prospectus relating
to the offering containing material information about the undersigned
Registrant or its securities provided by or on behalf of the
undersigned Registrant; and
(iv) Any other communication that is an offer in the offering
made by the undersigned Registrant to the purchaser.
(b) The undersigned Registrant hereby undertakes that, for purposes of
determining any liability under the Securities Act of 1933, as amended, each
filing of the Registrant's annual report pursuant to Section 13(a) or Section
15(d) of the Securities Exchange Act of 1934, as amended, (and, where
applicable, each filing of an employee benefit plan's annual report pursuant to
Section 15(d) of the Securities Exchange Act of 1934) that is incorporated by
reference in the registration statement shall be deemed to be a new registration
statement relating to the securities offered therein, and the offering of such
securities at that time shall be deemed to be the initial BONA FIDE offering
thereof.
(c) Insofar as indemnification for liabilities arising under the Securities
Act of 1933, as amended, may be permitted to directors, officers and controlling
persons of the Registrant pursuant to the foregoing provisions, or otherwise,
the Registrant has been advised that in the opinion of the Securities and
Exchange Commission such indemnification is against public policy as expressed
in the Act and is, therefore, unenforceable. In the event that a claim for
indemnification against such liabilities (other than the payment by the
Registrant of expenses incurred or paid by a director, officer or controlling
person of the Registrant in the successful defense of any action, suit or
proceeding) is asserted by such director, officer or controlling person in
connection with the securities being registered, the Registrant will, unless in
the opinion of its counsel the matter has been settled by controlling precedent,
submit to a court of appropriate jurisdiction the question whether such
indemnification by it is against public policy as expressed in the Act and will
be governed by the final adjudication of such issue.
II-5
(d) The undersigned Registrant hereby undertakes that:
(1) For purposes of determining any liability under the Securities Act
of 1933, the information omitted from the form of prospectus filed as part
of this Registration Statement in reliance upon Rule 430A and contained in
a form of prospectus filed by the Registrant pursuant to Rule 424(b)(1) or
(4) or 497(h) under the Securities Act of 1933 shall be deemed to be part
of this Registration Statement as of the time it was declared effective.
(2) For the purpose of determining any liability under the Securities
Act of 1933, each post-effective amendment that contains a form of
prospectus shall be deemed to be a new registration statement relating to
the securities offered therein, and the offering of such securities at that
time shall be deemed to be the initial bona fide offering thereof.
(e) The undersigned Registrant hereby undertakes to file an application for
the purpose of determining the eligibility of the trustee to act under
subsection (a) of Section 310 of the Trust Indenture Act in accordance with the
rules and regulations prescribed by the SEC under Section 305(b)(2) of the Trust
Indenture Act.
II-6
SIGNATURES
PURSUANT TO THE REQUIREMENTS OF THE SECURITIES ACT OF 1933, AS AMENDED,
METALINK LTD. CERTIFIES THAT IT HAS REASONABLE GROUNDS TO BELIEVE THAT IT MEETS
ALL OF THE REQUIREMENTS FOR FILING ON FORM F-3 AND HAS DULY CAUSED THIS
REGISTRATION STATEMENT TO BE SIGNED ON ITS BEHALF BY THE UNDERSIGNED, THEREUNTO
DULY AUTHORIZED, IN THE CITY OF YAKUM, ISRAEL ON AUGUST 25, 2008.
METALINK LTD.
By: /s/ Yuval Ruhama
--------------------
Yuval Ruhama
Chief Financial Officer
POWER OF ATTORNEY
Know all persons by these presents that each of the undersigned constitutes
and appoints Yuval Ruhama and Tzvi Shukman, and each of them, his or her true
and lawful attorneys-in-fact and agents with full and several power of
substitution, for and in his or her name, place and stead, in any and all
capacities, to sign any and all amendments, including post-effective amendments,
and supplements to this Registration Statement, and to file the same, with all
exhibits thereto and other documents in connection therewith, with the
Securities and Exchange Commission, granting unto said attorneys-in-fact and
agents full power and authority to do and perform each and every act and thing
requisite and necessary to be done in and about the premises, as fully to all
intents and purposes as they or he or she might or could do in person, hereby
ratifying and confirming all that said attorneys-in-fact and agents, or their
substitute or substitutes, may lawfully do or cause to be done by virtue hereof.
PURSUANT TO THE REQUIREMENTS OF THE SECURITIES ACT OF 1933, AS AMENDED,
THIS REGISTRATION STATEMENT HAS BEEN SIGNED BY THE FOLLOWING PERSONS IN THE
CAPACITIES AND ON THE DATES INDICATED.
NAME TITLE(S) DATE
---- -------- ----
* Chief Executive Officer and Director August 25, 2008
------------
Tzvi Shukman
/s/ Yuval Ruhama Chief Financial Officer August 25, 2008
---------------- (Principal Financial Officer and
Yuval Ruhama Principal Accounting Officer)
* Chairman of the Board of Directors August 25, 2008
-------------
Uzi Rozenberg
* Director August 25, 2008
-----------
Efi Shenhar
* Director August 25, 2008
------------
Naama Zeldis
II-7
NAME TITLE(S) DATE
---- -------- ----
* Director August 25, 2008
----------
Joe Markee
* Director August 25, 2008
-----------
Meir Bar-El
Authorized Representative in the United States:
METALINK INC.
By: * August 25, 2008
---------------------------
Tzvi Shukman
Director
* By /s/ Yuval Ruhama
---------------------------
Yuval Ruhama
(Attorney-in-Fact)
II-8
EXHIBIT INDEX
NUMBER DESCRIPTION
------ ----------------------------------------------------------------------
1 Form of Underwriting Agreement.*
3.1 Memorandum of Association, as amended (English translation accompanied
by Hebrew original), filed as Exhibit 4.1 to the Registrant's
Registration Statement on Form S-8, filed with the SEC on March 12,
2008, and incorporated herein by reference.
3.2 Articles of Association of the Registrant, as amended and restated,
filed as Exhibit 4.3 to the Registrant's Registration Statement on
Form S-8, filed with the SEC on April 17, 2001, and as Exhibit 4.2 to
the Registrant's Registration Statement on Form S-8, filed with the
SEC on March 12, 2008, and incorporated herein by reference.
4.1 Form of Ordinary Share Certificate Filed as Exhibit 4 to the
Registrant's Registration Statement on Form F-1, filed with the SEC on
November 10, 1999, and incorporated herein by reference.
4.2 Form of Purchase Contract Agreement (including form of Purchase
Contract Certificate).*
4.3 Form of Unit Agreement (including form of Unit Certificate).*
4.4 Form of Warrant Agreement (including form of Warrant Certificate).*
5.1 Opinion of Goldfarb, Levy, Eran, Meiri, Tzafrir & Co., Israeli counsel
to the Registrant. **
23.1 Consent of Brightman Almgor & Co., a member of Deloitte Touche
Tohmatsu.
23.2 Consent of Goldfarb, Levy, Eran, Meiri, Tzafrir & Co. (included in 5.1
above). **
24 Powers of attorney (included in the signature pages herein).**
----------
* If applicable, to be filed by amendment or incorporated by reference pursuant
to a report on Form 6-K.
** Previously filed.
II-9